syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
BIRDSHOT CHORIORETINOPATHY	2.00826446	75.34235119040808
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	75.03230046744748
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	57.052342195160755
PITUITARY APOPLEXY	1.3804945100000001	51.790839433990854
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.320621654	49.54464037337274
PERIPHERAL CONE DYSTROPHY	1.25	46.89518779215468
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1581403600000002	43.448967737498904
RETINITIS PIGMENTOSA 75; RP75	1.0666667	40.017228166510336
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.02930401	38.61552387533428
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.01243895	37.98281175067352
IDIOPATHIC INTRACRANIAL HYPERTENSION	1.00826446	37.82620095668434
MOWAT-WILSON SYNDROME; MOWS	1.000541419	37.53646219026713
TURCOT SYNDROME WITH POLYPOSIS	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
LEBER CONGENITAL AMAUROSIS 17	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.94270522	35.36667065963559
CRANIOPHARYNGIOMA	0.7988433730000001	29.969527994682615
LAFORA DISEASE	0.78194566	29.335590855168263
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.083800875229276
MENINGIOMA	0.735725	27.6015696307064
EARLY MYOCLONIC ENCEPHALOPATHY	0.719145614	26.979574894747504
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.704607014	26.434142592959493
ROLANDIC EPILEPSY	0.6114546	22.939422634701458
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.61096717	22.921136137593034
TSH-SECRETING PITUITARY ADENOMA	0.595264119	22.332018117149207
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.5893574	22.110420759756817
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5885869730000001	22.081517304680702
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.5638200600000001	21.152358075747138
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
INHALATIONAL ANTHRAX	0.5172414	19.404906069501596
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5171773	19.40250128427161
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.39011210088303
PERSISTENT PLACOID MACULOPATHY	0.5133333	19.25828920277318
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.5129803690000001	19.245048590355047
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.506359504	18.996659224337836
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.501086973	18.798854159229876
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	18.75807511686187
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
PINEOCYTOMA	0.5	18.75807511686187
PAPILLARY TUMOR OF THE PINEAL REGION	0.5	18.75807511686187
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.479112819	17.974468496506894
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.4519231	16.95441491369016
NELSON SYNDROME	0.4519231	16.95441491369016
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.44515221	16.700397187234138
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.43686985	16.389674925184355
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.434469819	16.29963500162276
CONGENITAL MYASTHENIC SYNDROME	0.434469819	16.29963500162276
JUVENILE GLAUCOMA	0.43124969999999996	16.178828533448293
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.424565264	15.928054228244582
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.363071274	13.621036460933478
LEBER HEREDITARY OPTIC NEUROPATHY	0.3581731	13.437275829278558
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.3547009	13.307012252437023
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.35468020399999994	13.306235818191784
NON-FUNCTIONING PITUITARY ADENOMA	0.345264119	12.952980558718272
PROLACTINOMA	0.345264119	12.952980558718272
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.34285699999999997	12.86267472068382
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.34285699999999997	12.86267472068382
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070946
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.33843317000000006	12.696709649795372
COG4-CDG	0.333878554	12.525837991682446
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.333333	12.505370905857834
XQ21 MICRODELETION SYNDROME	0.31775367299999996	11.920894533585527
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.30170260000000004	11.318720067505064
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
OPTIC ATROPHY 1; OPA1	0.28674451	10.757550115855501
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.28674451	10.757550115855501
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.2849752	10.69117241608547
RETINAL CAPILLARY MALFORMATION	0.283056	10.619171420556906
NARP SYNDROME	0.27838767299999995	10.444033763484757
WILLIAMS-BEUREN SYNDROME; WBS	0.26522724	9.950304981915902
RETINOSCHISIS OF FOVEA	0.26520889999999997	9.949616935720616
HYPEREKPLEXIA 1; HKPX1	0.25925926	9.726409347644044
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.25865907	9.703892529435265
NEOVASCULAR GLAUCOMA	0.25826446	9.689088281391536
UVEAL MELANOMA	0.25826446	9.689088281391536
CATARACT 7; CTRCT7	0.25826446	9.689088281391536
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.256035929	9.605482377595026
ALLAN-HERNDON-DUDLEY SYNDROME	0.25581395	9.597154580082295
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503891
OPTIC ATROPHY 9; OPA9	0.25549451	9.585170421051634
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25549451	9.585170421051634
PALLISTER-HALL SYNDROME	0.252439494	9.470557981829202
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	9.399504644255545
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.250541419	9.399349514974329
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.250541419	9.399349514974329
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.250541419	9.399349514974329
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	9.379037558430936
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	9.379037558430936
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.244048764	9.15577009457859
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
RETINITIS PUNCTATA ALBESCENS	0.2366153	8.876895142397613
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013937
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.229712554	8.61793068643638
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.135267030765908
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21647621	8.12135401638713
PITUITARY CARCINOMA	0.21382781	8.021996244108136
USHER SYNDROME TYPE 3	0.21096707000000003	7.914672292488515
RETINITIS PIGMENTOSA 18	0.2083333	7.815863381487438
CRI-DU-CHAT SYNDROME	0.20581395000000002	7.721347068396107
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.697875089002378
USHER SYNDROME TYPE 1	0.20250361400000003	7.597156005696004
PREECLAMPSIA/ECLAMPSIA 1	0.202435359	7.5945953408618
PLACENTAL INSUFFICIENCY	0.20189394000000002	7.5742833843184085
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.201086973	7.544009089112751
TRANSALDOLASE DEFICIENCY	0.20054555400000001	7.5236971325693585
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.200541419	7.523542003288142
LINEAR VERRUCOUS NEVUS SYNDROME	0.200541419	7.523542003288142
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.50323004674475
CARPENTER SYNDROME	0.2	7.50323004674475
HELLP SYNDROME	0.2	7.50323004674475
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.2	7.50323004674475
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.199003973	7.465862948175904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.19676231	7.381764382294523
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.18935242	7.103773835839156
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.864528843860672
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
UNILATERAL POLYMICROGYRIA	0.18042551999999998	6.768870914317728
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.17785471399999997	6.672424170199968
RIFT VALLEY FEVER	0.17547247900000001	6.5830518840479355
USHER SYNDROME TYPE 2	0.17493106000000003	6.562739927504543
MACULAR CORNEAL DYSTROPHY	0.173611	6.513216358227012
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.17144216	6.4318498309541035
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.393860752130533
SLC39A8-CDG	0.16976856899999998	6.369063139568294
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.16876496000000002	6.3314115935483795
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.16876496000000002	6.3314115935483795
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.167753973	6.293483253372037
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.166667	6.252704211004036
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.16333045000000002	6.127529699941705
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.16192107399999997	6.074655338189898
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.156639614	5.8765152913764975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.811133645395172
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.72728354897679
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14867095	5.577561695590431
JOUBERT SYNDROME 5	0.1464647	5.494791689137278
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.14394397299999998	5.400223716307073
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.14394397299999998	5.400223716307073
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.379911759763681
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.135149674	5.070295473822788
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.13277126	4.981066536880796
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.927090325796627
PINEOBLASTOMA	0.131035929	4.915963598379557
CONE-ROD DYSTROPHY 2	0.13071191000000001	4.903807652896977
RETINITIS PIGMENTOSA 58	0.1291667	4.845837322394324
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.12847589399999998	4.819920940715966
PANHYPOPHYSITIS	0.125	4.689518779215468
ADENOHYPOPHYSITIS	0.125	4.689518779215468
SHEEHAN SYNDROME	0.125	4.689518779215468
XP21 MICRODELETION SYNDROME	0.12495636299999999	4.687881686967718
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.122614673	4.60003049312691
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.11977006999999998	4.493311939623608
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427328
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.425523257443289
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.117676519	4.414769965785646
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.11660550999999998	4.374589831239976
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.11219797299999999	4.20923601098728
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.11219797299999999	4.20923601098728
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.11165665400000002	4.188927806058912
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	4.188924054443888
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.11165241899999999	4.188768925162671
GANGLIOCYTOMA	0.11111110000000002	4.168460720234303
SUDDEN INFANT DEATH SYNDROME	0.11111099999999999	4.168456968619278
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11111099999999999	4.168456968619278
MYOTONIA, POTASSIUM-AGGRAVATED	0.11111099999999999	4.168456968619278
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11111099999999999	4.168456968619278
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.11111099999999999	4.168456968619278
MUCOLIPIDOSIS III ALPHA/BETA	0.11111099999999999	4.168456968619278
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10869115400000001	4.077673662540803
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.10840760399999999	4.06703595814203
OPTIC ATROPHY 5; OPA5	0.10817310000000001	4.058238270847622
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.10768421900000001	4.039897337805209
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.1074498	4.0311028393835695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
SALT-AND-PEPPER SYNDROME	0.10543916400000002	3.9556715171422367
BILATERAL POLYMICROGYRIA	0.104660764	3.926468945800306
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.10397634	3.900791992192739
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390436
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.10139849000000001	3.804080984312735
NOCARDIOSIS	0.10111611900000002	3.7934875114550883
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09980951000000002	3.7444685719143527
MELAS	0.09963481000000002	3.7379145004685213
SENIOR-LOKEN SYNDROME 3	0.09917356000000001	3.720610176173216
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
SARCOSINEMIA	0.09849690400000001	3.695224648020665
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.69135860873908
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.69135860873908
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
SLC35A2-CDG	0.098026554	3.6775789267582333
LATE-ONSET RETINAL DEGENERATION; LORD	0.09762186000000002	3.662396365855547
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.09517155	3.5704701677763504
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955698
RETINAL CONE DYSTROPHY 3B	0.09234231000000001	3.4643279748890907
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	3.461311301248797
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.091820104	3.4447368161401384
PRADER-WILLI SYNDROME	0.091612819	3.436960280938941
AICA-RIBOSIDURIA	0.09145051900000001	3.430871409756008
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.09145051900000001	3.430871409756008
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.09127926000000001	3.424446431383131
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.0909091	3.410559453212615
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.0909091	3.410559453212615
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.0909091	3.410559453212615
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.0909091	3.410559453212615
STURGE-WEBER SYNDROME	0.08989881900000002	3.372657599438339
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.08882781000000001	3.3324774648926683
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08825100000000001	3.310837774276355
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.08740997	3.2792855664452856
NEUROTROPHIC KERATOPATHY	0.08593211	3.2238419486608745
SCHINZEL-GIEDION SYNDROME	0.08500986	3.1892426791078234
CITRULLINEMIA TYPE I	0.08387471900000001	3.146656558815364
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.08333334	3.12634610291798
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.08241761	3.0919914386644525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	3.0909876565487995
WHITE-SUTTON SYNDROME; WHSUS	0.08148856400000001	3.0571372093544125
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.080910854	3.0354637542028877
GAUCHER DISEASE TYPE 2	0.08068786000000001	3.027097877797669
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08063321400000001	3.025047770251997
CONE-ROD DYSTROPHY 10	0.0803653	3.014996668378279
USHER SYNDROME	0.07956821	2.98509292018848
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9653819348556816
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.07883488300000001	2.957581314286034
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.07747587300000001	2.9065964909569018
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	2.885858576043755
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0761986	2.858678125199422
SENIOR-LOKEN SYNDROME 4; SLSN4	0.07583329999999999	2.8449734755190423
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07550507999999999	2.8326599246893296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.074003673	2.7763329141153656
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.073777854	2.7678610545857363
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07332254	2.750779426158219
CONE-ROD DYSTROPHY 8; CORD8	0.0726908	2.727078973409566
LEIGH SYNDROME; LS	0.07251557300000001	2.720505130952562
CONE-ROD DYSTROPHY 6; CORD6	0.07216120999999999	2.707210795407288
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.07197001900000001	2.7000380451279526
SPONTANEOUS PERIODIC HYPOTHERMIA	0.07197001900000001	2.7000380451279526
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.07197001900000001	2.7000380451279526
TAKAYASU ARTERITIS	0.07197001900000001	2.7000380451279526
SCLERODERMA	0.07197001900000001	2.7000380451279526
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.683537729448306
ALAND ISLAND EYE DISEASE	0.07150901	2.6827427622248536
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.07143619	2.6800108361648336
CLEFT LIP AND ALVEOLUS	0.07142860000000001	2.67972608858456
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	2.67972608858456
RELAPSING POLYCHONDRITIS	0.07142860000000001	2.67972608858456
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.07142860000000001	2.67972608858456
PYCNODYSOSTOSIS	0.07142860000000001	2.67972608858456
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.07142860000000001	2.67972608858456
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.655370603852826
DISTAL MONOSOMY 12Q	0.069239254	2.5975902551349574
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.069065519	2.5910723867741017
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06856063999999999	2.572131270360249
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0685241	2.5707604302307097
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.06810996999999999	2.555223866934417
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.067595454	2.5359212073807624
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.067212254	2.5215450186111994
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
RETINITIS PIGMENTOSA 41	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	2.4723808165367593
RETINITIS PIGMENTOSA 20	0.06566456	2.4634814979913666
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.4127236473711475
DIETHYLSTILBESTROL SYNDROME	0.06395896000000001	2.399493952152728
BRONCHOPULMONARY DYSPLASIA	0.06395896000000001	2.399493952152728
CHROMOSOME 16P13.2 DELETION SYNDROME	0.063586973	2.3855384319757356
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.063586973	2.3855384319757356
LEBER CONGENITAL AMAUROSIS	0.063586973	2.3855384319757356
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.06326349	2.37340259514968
HADDAD SYNDROME	0.063041419	2.3650713461511264
MULTIPLE SYSTEM ATROPHY	0.0625	2.344759389607734
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.0625	2.344759389607734
ARNOLD-CHIARI MALFORMATION TYPE I	0.0625	2.344759389607734
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.0625	2.344759389607734
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0625	2.344759389607734
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0625	2.344759389607734
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0625	2.344759389607734
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0625	2.344759389607734
2Q24 MICRODELETION SYNDROME	0.061910969	2.322661214119414
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.06175601	2.316847748995346
RHEUMATOID ARTHRITIS	0.0607197	2.2779693873466353
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.060640982999999996	2.2750162285486875
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.059986743999999995	2.250471699935926
HYPOPLASMINOGENEMIA	0.0596073	2.2362364218266415
JOUBERT SYNDROME 2	0.059265714	2.2234214301329045
JOUBERT SYNDROME 3; JBTS3	0.05872016	2.2029543443082953
CONE-ROD DYSTROPHY 20; CORD20	0.05802111	2.176728679487411
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.05802111	2.176728679487411
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.057818869999999994	2.1691414132641427
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.167604751750569
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.056642573	2.1250112782926642
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.056642573	2.1250112782926642
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0563492	2.114005052750146
JOUBERT SYNDROME 7	0.056101154	2.1046993217492718
JOUBERT SYNDROME 1	0.056101154	2.1046993217492718
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492718
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.056097019000000005	2.1045441924680555
ACUTE BILIRUBIN ENCEPHALOPATHY	0.056097019000000005	2.1045441924680555
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.056097019000000005	2.1045441924680555
WOLFRAM SYNDROME	0.056097019000000005	2.1045441924680555
APNEA, OBSTRUCTIVE SLEEP	0.0555984	2.085837927154666
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
GITELMAN SYNDROME	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.05465477399999999	2.0504367123742178
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.054608172999999996	2.048688422257176
CHROMOSOME 1P36 DELETION SYNDROME	0.05387077299999999	2.0210240130748285
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.053637669	2.0122788483907468
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.052020019	1.9515908479651636
JUVENILE XANTHOGRANULOMA	0.051742760000000006	1.9411891576675118
PEHO SYNDROME	0.051484814	1.9315120167793232
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05128121399999999	1.9238737285917369
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.05044311	1.8924312930162526
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
MOHR-TRANEBJAERG SYNDROME	0.04894842	1.836356278423408
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04851715	1.8201766883121098
TRICHOTHIODYSTROPHY	0.04848550399999999	1.818989452221813
17P11.2 MICRODUPLICATION SYNDROME	0.04840585399999999	1.8160012908556968
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.04776785	1.7920658369419806
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.047441893999999984	1.7798372226763965
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.04734844	1.7763311883724546
NEUROFIBROMATOSIS TYPE 1	0.047184279	1.7701724996339363
MENTAL RETARDATION, X-LINKED 98; MRX98	0.047182633	1.7701107480506517
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046841813999999996	1.757324531244144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.046541473	1.746056893166797
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.046541473	1.746056893166797
ADENYLOSUCCINASE DEFICIENCY	0.046541473	1.746056893166797
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.046000054	1.7257449366234048
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.046000054	1.7257449366234048
HEREDITARY METHEMOGLOBINEMIA	0.045995919	1.7255898073421885
CONE-ROD DYSTROPHY, X-LINKED, 3	0.04575352	1.7164959300416838
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0454545	1.7052778507987958
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0454545	1.7052778507987958
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.04542484399999999	1.7041652718474642
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.04540046	1.7032504780401654
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04537224	1.7021917722805697
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.04537224	1.7021917722805697
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.045114299999999996	1.6925148564892827
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.6618886973105835
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.044048764000000004	1.652540047833842
HYDROXYKYNURENINURIA	0.044023854	1.65160552053152
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.6514503912503038
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.6311384347069111
LICHTENSTEIN SYNDROME	0.043478300000000004	1.6311384347069111
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.6311384347069111
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.6311384347069111
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	1.6311384347069111
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	1.6311384347069111
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.6311384347069111
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.6311384347069111
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.6311384347069111
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.6311384347069111
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.6311384347069111
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.6311384347069111
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6232024183510698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6225267524853604
CANAVAN DISEASE	0.043061100000000005	1.615486696829402
BIOTINIDASE DEFICIENCY	0.042873574	1.6084514432406722
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
ALG13-CDG	0.0426748	1.600994207994114
WEST SYNDROME	0.0426748	1.600994207994114
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0426748	1.600994207994114
CHERUBISM	0.04227	1.5858076703795028
COG2-CDG	0.04221225399999999	1.5836412627681058
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.576501939378628
GYRATE ATROPHY OF CHOROID AND RETINA	0.041540719000000004	1.5584478548209024
ALPERS-HUTTENLOCHER SYNDROME	0.041389704	1.5527823533933565
MENTAL RETARDATION, X-LINKED 106; MRX106	0.040905854	1.5346301641027693
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.040901719	1.534475034821553
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04084415	1.5323152675687477
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04020156	1.508207764590059
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.040015769	1.5012376015219853
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.039661713999999994	1.4879548209509839
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.039661713999999994	1.4879548209509839
OPTIC ATROPHY 8	0.03951446	1.4824304177644676
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.039283524	1.4737665880940922
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
ADNP SYNDROME	0.039262129	1.4729639300598416
OCULOCUTANEOUS ALBINISM	0.03920057	1.470654473367604
OPTIC PATHWAY GLIOMA	0.039185033	1.4700715849414225
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.039092333	1.4665938378147563
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.039092333	1.4665938378147563
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.038585553999999994	1.44758144071546
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
ACHROMATOPSIA	0.038194439999999996	1.4329083491329473
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4284161653039615
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
MARSHALL-SMITH SYNDROME; MRSHSS	0.03783066	1.4192607240009236
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310352
16P13.11 MICRODELETION SYNDROME	0.037582554	1.4099527420310352
COSTELLO SYNDROME; CSTLO	0.037520314	1.407617736840488
13Q12.3 MICRODELETION SYNDROME	0.03740978	1.4034709266905536
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.037366263	1.4018383363808329
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.037290064	1.3989796432491732
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.037274100000000004	1.3983807354268423
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
CHRISTIANSON SYNDROME	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
OSTEOPETROSIS AND RELATED DISORDERS	0.0369623	1.386683199783967
MYHRE SYNDROME	0.03695235299999999	1.3863100266375918
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.036780523999999995	1.3798636640590816
MACULAR DYSTROPHY, RETINAL, 2	0.03674451	1.3785125574245645
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.03674451	1.3785125574245645
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.03674451	1.3785125574245645
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.03674451	1.3785125574245645
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.03674451	1.3785125574245645
ACHROMATOPSIA 7; ACHM7	0.03674451	1.3785125574245645
STARGARDT DISEASE	0.03674451	1.3785125574245645
19P13.3 MICRODUPLICATION SYNDROME	0.036415833999999994	1.366181899230345
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.3603301301168889
ALSTROM SYNDROME; ALMS	0.036110713999999995	1.354734971471031
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.03568607	1.338803963371182
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
HALLERMANN-STREIFF SYNDROME; HSS	0.03561365	1.3360870437712553
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.035520753999999995	1.3326019434791434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.035146913999999994	1.3185769058757681
DYSOSTEOSCLEROSIS	0.035136919	1.3182019319541822
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.03506331299999999	1.3154405182000786
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.034712153999999995	1.3022663844001545
SAETHRE-CHOTZEN SYNDROME	0.034708019	1.302111255118938
PRADER-WILLI SYNDROME; PWS	0.034678663	1.3010099310126768
DOORS SYNDROME	0.034614804	1.2986141871749015
CONE-ROD DYSTROPHY 17; CORD17	0.03441456	1.2911018031874997
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034152039999999995	1.2812530634281425
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
CHROMOSOME 17Q12 DELETION SYNDROME	0.03397144	1.2744776466959322
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2306668116790926
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
RETINITIS PIGMENTOSA 11	0.03279521	1.2303500253065192
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.03271235399999999	1.2272415871627536
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.03252151	1.220081854987549
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
AICARDI SYNDROME	0.0322581	1.2101997258544839
GIANT CELL ARTERITIS	0.03207396	1.2032915019504458
X-LINKED ADRENOLEUKODYSTROPHY	0.03207396	1.2032915019504458
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.032062943999999996	1.202878224039471
TYSHCHENKO SYNDROME	0.031676154	1.1883673522905691
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.03152996	1.1828827162233002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.03134496	1.1759422284300614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03134496	1.1759422284300614
CRANIOSYNOSTOSIS 2	0.031295359	1.1740813898623186
1P36 DELETION SYNDROME	0.031278533	1.1734501431184856
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.03125	1.172379694803867
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.03125	1.172379694803867
CONE-ROD DYSTROPHY 18	0.03125	1.172379694803867
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.1715134468949702
TURNPENNY-FRY SYNDROME; TPFS	0.031010894	1.1634093581860823
PITT-HOPKINS SYNDROME	0.030929283	1.1603476276493578
PRADER-WILLI-LIKE SYNDROME	0.030898783000000003	1.1592033850672292
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.03082266	1.1563475431629877
OCULODENTODIGITAL DYSPLASIA	0.030732979	1.1529830572938768
ACHONDROPLASIA	0.03046534	1.1429422723614735
BARATELA-SCOTT SYNDROME	0.030387863999999997	1.1400356711059652
BAKER-GORDON SYNDROME; BAGOS	0.030357363999999998	1.1388914285238365
WILLIAMS SYNDROME	0.03019156	1.1326711007504844
CARTILAGE-HAIR HYPOPLASIA	0.03019156	1.1326711007504844
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.03019156	1.1326711007504844
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.030092559999999997	1.1289570018773458
1Q21.1 MICRODELETION SYNDROME	0.030007913	1.1257813723085117
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.029946643	1.1234827577836914
RETINAL CONE DYSTROPHY 4	0.02993567	1.1230710930671768
RETINITIS PIGMENTOSA 4; RP4	0.029833600000000002	1.1192418196128207
VASCULAR EHLERS-DANLOS SYNDROME	0.029782214	1.1173140147169107
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1146413266581099
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.029658373000000002	1.112667977155816
SCLEROSTEOSIS 1; SOST1	0.02954106	1.1082668450234472
USHER SYNDROME, TYPE IIIA	0.029304010000000002	1.099373641610543
CAVITARY OPTIC DISC ANOMALIES; CODA	0.029304010000000002	1.099373641610543
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.029304010000000002	1.099373641610543
RETINITIS PIGMENTOSA 78; RP78	0.029304010000000002	1.099373641610543
BECKWITH-WIEDEMANN SYNDROME	0.029236659999999998	1.0968469288923015
XIA-GIBBS SYNDROME	0.029116954	1.0923560206124234
AURICULOCONDYLAR SYNDROME	0.029116954	1.0923560206124234
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.029116954	1.0923560206124234
MUCOPOLYSACCHARIDOSIS, TYPE II	0.029112819	1.0922008913312071
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.029112819	1.0922008913312071
POTOCKI-LUPSKI SYNDROME	0.028864713	1.0828929093613189
RAHMAN SYNDROME	0.028701813999999996	1.0767815660043951
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	1.0718889347878144
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	1.0718889347878144
HURLER-SCHEIE SYNDROME	0.0285714	1.0718889347878144
SCHEIE SYNDROME	0.0285714	1.0718889347878144
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	1.0718889347878144
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0285714	1.0718889347878144
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.028369172999999998	1.0643021562744992
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0632588696526497
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0632588696526497
PEHO-LIKE SYNDROME; PEHOL	0.028270504	1.060600475247088
BETA-UREIDOPROPIONASE DEFICIENCY	0.028270504	1.060600475247088
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.02822104	1.058744776391927
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.02822104	1.058744776391927
KOOLEN-DE VRIES SYNDROME	0.028113973	1.0547280347348529
AMISH INFANTILE EPILEPSY SYNDROME	0.027970509999999997	1.0493458552738721
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.027807464	1.0432289970428645
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623315
16P13.2 MICRODELETION SYNDROME	0.027734223	1.0404812766835965
SCHAAF-YANG SYNDROME; SHFYNG	0.027734223	1.0404812766835965
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.027621859999999998	1.0362658494948844
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.027572554	1.0344160781914604
DISTAL MONOSOMY 6P	0.027572554	1.0344160781914604
RENPENNING SYNDROME	0.027568419	1.0342609489102441
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
EMANUEL SYNDROME	0.027337722999999998	1.0256061231159248
BARDET-BIEDL SYNDROME 21; BBS21	0.0273007	1.0242171626858219
STÜVE-WIEDEMANN SYNDROME	0.0272822	1.023523113906498
CRANIOECTODERMAL DYSPLASIA	0.027027	1.0139489923668517
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.027027	1.0139489923668517
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
ACRAL PEELING SKIN SYNDROME	0.027027	1.0139489923668517
MICROPHTHALMIA, ISOLATED 1	0.027027	1.0139489923668517
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.027027	1.0139489923668517
HYPEROPIA, HIGH	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.027027	1.0139489923668517
NANOPHTHALMOS	0.027027	1.0139489923668517
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.027027	1.0139489923668517
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.027027	1.0139489923668517
RETINITIS PIGMENTOSA 83; RP83	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 79	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 19	0.02677111	1.004348984683544
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 14	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 72; RP72	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 10; RP10	0.02677111	1.004348984683544
CHERUBISM	0.02677111	1.004348984683544
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.9942027418528336
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.026474383	0.9932169299731419
MICROSPORIDIOSIS	0.026047279	0.9771936321437176
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.026035464	0.9767503788287061
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.025932964	0.9729049734297495
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.025932964	0.9729049734297495
1P21.3 MICRODELETION SYNDROME	0.025683563999999996	0.9635484455614586
CONGENITAL ENTEROVIRUS INFECTION	0.025644760000000003	0.9620926688677894
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.025644760000000003	0.9620926688677894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025621114	0.9612055619793627
TOXIC EPIDERMAL NECROLYSIS	0.025505859999999998	0.956881675600325
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025147103999999997	0.9434225316070752
GORLIN-CHAUDHRY-MOSS SYNDROME	0.025138009999999995	0.9430813597368496
CARDIOFACIOCUTANEOUS SYNDROME	0.025077913999999996	0.9408267891724038
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02507556	0.9407384761547538
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.02461252	0.9233669979505303
CROUZON SYNDROME	0.024539279	0.920619277591262
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.024539279	0.920619277591262
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.024355054	0.9137078648144545
ISOLATED PLAGIOCEPHALY	0.024355054	0.9137078648144545
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.024350919000000002	0.9135527355332381
SNEDDON SYNDROME	0.024350919000000002	0.9135527355332381
LYNCH SYNDROME	0.024350919000000002	0.9135527355332381
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.024350919000000002	0.9135527355332381
FAMILIAL COLORECTAL CANCER TYPE X	0.024350919000000002	0.9135527355332381
FAMILIAL THROMBOCYTOSIS	0.024350919000000002	0.9135527355332381
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02418584	0.907359606968805
AGEL AMYLOIDOSIS	0.02399786	0.9003073210478696
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.023814213	0.893417592605897
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.8932407789898456
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.8932407789898456
FUNCTIONING GONADOTROPIC ADENOMA	0.0238095	0.8932407789898456
PITUICYTOMA	0.0238095	0.8932407789898456
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0238095	0.8932407789898456
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.0238095	0.8932407789898456
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.8932407789898456
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.0238095	0.8932407789898456
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.8932407789898456
CRYPTOCOCCOSIS	0.023806919000000003	0.8931439498060924
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.023678113999999997	0.8883116820752373
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.023429283	0.8789765008964296
16P11.2P12.2 MICRODELETION SYNDROME	0.023272794	0.8731056360625045
6Q25 MICRODELETION SYNDROME	0.023029922999999997	0.8639940511390897
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02272724	0.8526385502378955
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.022643378999999998	0.8494924083631452
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064703
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8446087435064703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.8424834535957298
INFANTILE REFSUM DISEASE	0.022363573	0.838995164430848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.022342309999999997	0.8381974585284282
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.022342309999999997	0.8381974585284282
HERMANSKY-PUDLAK SYNDROME	0.022342309999999997	0.8381974585284282
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.022342309999999997	0.8381974585284282
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.022342309999999997	0.8381974585284282
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.022015233	0.8259267886584326
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.021993514	0.8251119753915064
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.02196306	0.8239694585522885
SIALURIA	0.021920273	0.8223642550322383
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.021920273	0.8223642550322383
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.8223642550322383
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021920273	0.8223642550322383
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.021911	0.822016367771121
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02170111	0.8141421029985647
GALACTOSEMIA	0.021492933000000002	0.8063321033913589
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.021423883	0.8037416132177202
OROFACIODIGITAL SYNDROME TYPE 14	0.021378854	0.8020522984888457
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.021378854	0.8020522984888457
ALEXANDER DISEASE	0.021374719	0.8018971692076293
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8018971692076293
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8018971692076293
COFFIN-LOWRY SYNDROME	0.021374719	0.8018971692076293
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.021374719	0.8018971692076293
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.7990607606692086
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
RETINITIS PIGMENTOSA	0.0212766	0.7982161220628465
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.7982161220628465
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 6	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 69	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 1	0.0212766	0.7982161220628465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020937633	0.785499385166572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.020937633	0.785499385166572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.020937633	0.785499385166572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.020937633	0.785499385166572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.020937633	0.785499385166572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.020937633	0.785499385166572
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.020937633	0.785499385166572
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.020928259999999997	0.7851477462904312
CRANDALL SYNDROME	0.0208333	0.7815852126642369
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.7815852126642369
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.7815852126642369
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642369
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.7815852126642369
POLYARTERITIS NODOSA	0.0208333	0.7815852126642369
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642369
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642369
DERMOIDS OF CORNEA	0.0208333	0.7815852126642369
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.7815852126642369
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7815852126642369
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642369
INFANTILE MYOFIBROMATOSIS	0.0208333	0.7815852126642369
ACROMEGALY	0.0208333	0.7815852126642369
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642369
IMINOGLYCINURIA	0.0208333	0.7815852126642369
SOMATOMAMMOTROPINOMA	0.0208333	0.7815852126642369
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642369
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642369
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.7815852126642369
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642369
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642369
GAUCHER DISEASE, TYPE I	0.0208333	0.7815852126642369
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.7815852126642369
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642369
STICKLER SYNDROME, TYPE III	0.0208333	0.7815852126642369
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642369
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7815852126642369
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7815852126642369
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.7815852126642369
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7815852126642369
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642369
GLAUCOMA - SLEEP APNEA	0.0208333	0.7815852126642369
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7815852126642369
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642369
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642369
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642369
HYPOCHONDROPLASIA	0.0208333	0.7815852126642369
611426 TENTED EYEBROWS	0.0208333	0.7815852126642369
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642369
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0208333	0.7815852126642369
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642369
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642369
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642369
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.7815852126642369
APNEA, CENTRAL SLEEP	0.0208333	0.7815852126642369
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642369
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.020823294	0.7812098260649981
OPTIC ATROPHY 11; OPA11	0.020823294	0.7812098260649981
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.020823294	0.7812098260649981
ALSTRÖM SYNDROME	0.020809673	0.7806988185826647
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.020809673	0.7806988185826647
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.020762933	0.7789453137207404
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
SPINOCEREBELLAR ATAXIA TYPE 7	0.020648064	0.7746358710595428
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.020643039999999998	0.7744473899207684
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443213999999998	0.7669506876841644
STEVENS-JOHNSON SYNDROME	0.02040596	0.7655530610233574
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.020392079	0.765032299341963
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.020392079	0.765032299341963
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.020304314	0.7617396944167003
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02027774	0.7607427402403892
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02027774	0.7607427402403892
RETINITIS PIGMENTOSA 80; RP80	0.020268254	0.7603868620392721
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.020264119	0.7602317327580557
MIRAGE SYNDROME; MIRAGE	0.020222313000000002	0.7586633325813847
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.020217379	0.7584782278961315
GAUCHER DISEASE, PERINATAL LETHAL	0.020097979	0.7539987995582248
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.020053968999999998	0.7523477137864386
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0197227	0.7399197762146632
OCULOCEREBRORENAL SYNDROME OF LOWE	0.019688669	0.7386430641060594
MENKES DISEASE	0.019676759000000002	0.7381962467567759
LEUKOCYTE ADHESION DEFICIENCY	0.019676759000000002	0.7381962467567759
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.7381662713527389
XQ12-Q13.3 DUPLICATION SYNDROME	0.01967596	0.7381662713527389
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.019234639	0.7216096064154419
CONE DYSTROPHY 3	0.01919311	0.7200515982123855
CONE-ROD DYSTROPHY 16	0.01919311	0.7200515982123855
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395407
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.018988524	0.7123763191006689
PERMANENT NEONATAL DIABETES MELLITUS	0.018741004	0.7030903215948175
TRANSIENT NEONATAL DIABETES MELLITUS	0.018741004	0.7030903215948175
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.018610693	0.6982015545417108
JOUBERT SYNDROME WITH OCULAR DEFECT	0.018610693	0.6982015545417108
CHARGE SYNDROME	0.018568493999999998	0.6966184105179979
TRISOMY 13	0.018564358999999996	0.6964632812367813
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
DISTAL MONOSOMY 10Q	0.018499343	0.6940241312131857
6Q TERMINAL DELETION SYNDROME	0.018448113000000002	0.6921021788367121
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.018448113000000002	0.6921021788367121
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.018392944	0.6900324503444678
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.018358309	0.6887330784811228
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.018329943	0.687668895363593
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.018069274	0.6778895979983183
PREECLAMPSIA	0.018022939999999998	0.6761513246933889
FETAL PARVOVIRUS SYNDROME	0.018022939999999998	0.6761513246933889
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017853804	0.6698059931074579
GABRIELE-DE VRIES SYNDROME	0.01784739	0.6695653645198588
CURRARINO SYNDROME	0.017786954	0.6672980384643334
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.017786954	0.6672980384643334
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.017786954	0.6672980384643334
WHIM SYNDROME	0.017782819000000002	0.667142909183117
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.017782819000000002	0.667142909183117
PGM3-CDG	0.017782819000000002	0.667142909183117
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01752372	0.6574225121737094
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01752372	0.6574225121737094
ZTTK SYNDROME; ZTTKS	0.017465373	0.6552335573560223
AYMÉ-GRIPP SYNDROME	0.017408714	0.6531079297999297
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.017404579	0.6529528005187133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.017317623	0.6496905461589897
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
CALCIPHYLAXIS	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
RETICULAR DYSGENESIA	0.0172414	0.6468309526397246
DESMOID TUMOR	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
CYCLIC NEUTROPENIA	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
WISKOTT-ALDRICH SYNDROME	0.0172414	0.6468309526397246
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
OMENN SYNDROME	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
BULLOUS IMPETIGO	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0172414	0.6468309526397246
MELIOIDOSIS	0.0172414	0.6468309526397246
RAT-BITE FEVER	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
LAMELLAR ICHTHYOSIS	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
LEGIONELLOSIS	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
RADIATION PROCTITIS	0.0172414	0.6468309526397246
HIRSCHSPRUNG DISEASE	0.0172414	0.6468309526397246
NEUROLEPTIC MALIGNANT SYNDROME	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
IMMUNODEFICIENCY 46; IMD46	0.0172414	0.6468309526397246
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
PLAGUE	0.0172414	0.6468309526397246
RETICULAR DYSGENESIS	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0172414	0.6468309526397246
PYOMYOSITIS	0.0172414	0.6468309526397246
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
CLASSIC GALACTOSEMIA	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
ACQUIRED PURPURA FULMINANS	0.0172414	0.6468309526397246
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0172414	0.6468309526397246
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
X-LINKED AGAMMAGLOBULINEMIA	0.0172414	0.6468309526397246
SEVERE COMBINED IMMUNODEFICIENCY	0.0172414	0.6468309526397246
FELTY SYNDROME	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
CHRONIC GRANULOMATOUS DISEASE	0.0172414	0.6468309526397246
SECONDARY SHORT BOWEL SYNDROME	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
ISOLATED AGAMMAGLOBULINEMIA	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
CONGENITAL DISORDER OF GLYCOSYLATION	0.017215973	0.6458770294877316
MULTIPLE CARBOXYLASE DEFICIENCY	0.017215973	0.6458770294877316
CEDNIK SYNDROME	0.017215973	0.6458770294877316
ALG11-CDG	0.017215973	0.6458770294877316
RECOMBINANT 8 SYNDROME	0.017215973	0.6458770294877316
ALG3-CDG	0.017215973	0.6458770294877316
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.017098354	0.6414644174133912
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.017040423000000002	0.6392910693142015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.017040423000000002	0.6392910693142015
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.017040423000000002	0.6392910693142015
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.017021764	0.6385910554669905
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.017021763999999998	0.6385910554669904
XYLOSIDASE DEFICIENCY	0.016982219000000003	0.6371074793059979
OROFACIODIGITAL SYNDROME TYPE 2	0.016847064	0.6320369840211588
GERODERMA OSTEODYSPLASTICA	0.016674553999999998	0.625565072944339
FARBER DISEASE	0.016674553999999998	0.625565072944339
CONGENITAL HYPOTHYROIDISM	0.016674553999999998	0.625565072944339
INSULINOMA	0.016670419	0.6254099436631226
CHOREOACANTHOCYTOSIS	0.016670419	0.6254099436631226
DYSEQUILIBRIUM SYNDROME	0.016670419	0.6254099436631226
DPM1-CDG	0.016670419	0.6254099436631226
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016670419	0.6254099436631226
CEREBROTENDINOUS XANTHOMATOSIS	0.016670419	0.6254099436631226
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.016670419	0.6254099436631226
LINEAR NEVUS SEBACEUS SYNDROME	0.016670419	0.6254099436631226
MPDU1-CDG	0.016670419	0.6254099436631226
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016670419	0.6254099436631226
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.016670419	0.6254099436631226
BENIGN FAMILIAL INFANTILE EPILEPSY	0.016670419	0.6254099436631226
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.016499004	0.618979112770809
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.01649786	0.6189361942949415
NON-DISTAL MONOSOMY 20Q	0.016494869000000002	0.6188239834895926
TRISOMY 8P	0.016494869000000002	0.6188239834895926
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.016370333	0.6141518722040855
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.016334883	0.6128219246783
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.016334883	0.6128219246783
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.016334882999999998	0.6128219246782999
PHELAN-MCDERMID SYNDROME	0.016334882999999998	0.6128219246782999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.016334882999999998	0.6128219246782999
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.016334882999999998	0.6128219246782999
TETRASOMY 9P	0.016314213	0.612046465852969
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.016314212999999998	0.6120464658529688
GAUCHER DISEASE	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.016133958999999996	0.6052840297087392
WAARDENBURG SYNDROME	0.016128999999999998	0.6050979871197302
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.6050979871197302
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.6050979871197302
ALKAPTONURIA	0.016128999999999998	0.6050979871197302
STERNAL CLEFT	0.016128999999999998	0.6050979871197302
X-LINKED RETINOSCHISIS	0.016128999999999998	0.6050979871197302
NARCOLEPSY TYPE 1	0.016128999999999998	0.6050979871197302
SILENT SINUS SYNDROME	0.016128999999999998	0.6050979871197302
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.016128999999999998	0.6050979871197302
EEM SYNDROME	0.016128999999999998	0.6050979871197302
AMYLOIDOSIS	0.016128999999999998	0.6050979871197302
CENTRAL NEUROCYTOMA	0.016128999999999998	0.6050979871197302
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.6050979871197302
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.6050979871197302
TOWNES-BROCKS SYNDROME	0.016128999999999998	0.6050979871197302
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016128999999999998	0.6050979871197302
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.6050979871197302
WAARDENBURG SYNDROME TYPE 1	0.016128999999999998	0.6050979871197302
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.6050979871197302
DIPROSOPUS	0.016128999999999998	0.6050979871197302
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.6050979871197302
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.6050979871197302
ARACHNOIDITIS	0.016128999999999998	0.6050979871197302
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.6050979871197302
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.6050979871197302
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.6050979871197302
ACRORENAL SYNDROME	0.016128999999999998	0.6050979871197302
SOTOS SYNDROME 2	0.01595345	0.5985120269462001
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.01595345	0.5985120269462001
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015909933	0.5968794366364791
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01588063	0.5957801008861803
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015852263999999998	0.5947159177686504
JOUBERT SYNDROME 30; JBTS30	0.015840743	0.5942836942018078
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.01579181	0.592447916422421
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.015592539999999998	0.5849720731653468
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5804106345230292
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5804106345230292
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5804106345230292
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01522724	0.5712674234849675
JACOBSEN SYNDROME	0.01522724	0.5712674234849675
FUMARASE DEFICIENCY; FMRD	0.015204414	0.5704110798397325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5704110798397325
COFFIN-SIRIS SYNDROME 1; CSS1	0.015154483	0.5685378609424124
NEMALINE MYOPATHY 2; NEM2	0.01507321	0.5654888108644671
STICKLER SYNDROME	0.01503311	0.5639844132400947
LOWE OCULOCEREBRORENAL SYNDROME	0.015014439000000001	0.5632839491990809
COHEN SYNDROME	0.015014439000000001	0.5632839491990809
CINCA SYNDROME	0.014973014000000002	0.561729842675649
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.014863313999999999	0.5576143209950093
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.014829979	0.5563637201269682
ADRENOLEUKODYSTROPHY	0.014829979	0.5563637201269682
DONNAI-BARROW SYNDROME	0.014785572999999998	0.5546977779596893
HSD10 DISEASE	0.014785572999999998	0.5546977779596893
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.014668233000000001	0.5502956328912644
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.014668233000000001	0.5502956328912644
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5499439940151235
FANCONI ANEMIA	0.014613064	0.54822590439902
CONGENITAL TOXOPLASMOSIS	0.014548833	0.5458162045533578
ÅLAND ISLANDS EYE DISEASE	0.014503519999999999	0.5441162352378169
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.014503519999999999	0.5441162352378169
RETINAL DYSTROPHY AND OBESITY; RDOB	0.014503519999999999	0.5441162352378169
EDICT SYNDROME	0.014503519999999999	0.5441162352378169
MEGALOCORNEA	0.014503519999999999	0.5441162352378169
RETINOPATHY OF PREMATURITY	0.014427460000000001	0.54126275685104
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.014420272999999999	0.5409931282793101
DUANE RETRACTION SYNDROME	0.014420272999999999	0.5409931282793101
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.014420272999999999	0.5409931282793101
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.014420272999999999	0.5409931282793101
DIGEORGE SYNDROME; DGS	0.014420272999999999	0.5409931282793101
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.014420272999999999	0.5409931282793101
CHÉDIAK-HIGASHI SYNDROME	0.014420272999999999	0.5409931282793101
MUENKE SYNDROME	0.014420272999999999	0.5409931282793101
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.014420272999999999	0.5409931282793101
PHACE SYNDROME	0.014420272999999999	0.5409931282793101
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.01428856	0.5360517635835758
SENIOR-LOKEN SYNDROME	0.014244153999999998	0.534385821416297
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.534385821416297
MEDULLOBLASTOMA	0.014244153999999998	0.534385821416297
JOUBERT SYNDROME 35; JBTS35	0.014244153999999998	0.534385821416297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.014244153999999998	0.534385821416297
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.014244153999999998	0.534385821416297
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.534385821416297
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.534385821416297
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.014244153999999998	0.534385821416297
NEURAMINIDASE DEFICIENCY	0.014240018999999998	0.5342306921350805
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.014240018999999998	0.5342306921350805
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.014240018999999998	0.5342306921350805
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.014240018999999998	0.5342306921350805
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.014240018999999998	0.5342306921350805
KNOBLOCH SYNDROME	0.014240018999999998	0.5342306921350805
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.014240018999999998	0.5342306921350805
SIALIDOSIS TYPE 1	0.014240018999999998	0.5342306921350805
BRITTLE CORNEA SYNDROME	0.01407841	0.5281677446119587
WRINKLY SKIN SYNDROME	0.013933794	0.5227423090297585
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013933794	0.5227423090297585
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.013878854	0.5206811717359177
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.013878854	0.5206811717359177
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.013874718999999999	0.5205260424547011
PFEIFFER SYNDROME TYPE 3	0.013874718999999999	0.5205260424547011
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.013874718999999999	0.5205260424547011
CLASSIC HOMOCYSTINURIA	0.013874718999999999	0.5205260424547011
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.013874718999999999	0.5205260424547011
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.013845363	0.5194247183484401
MONOSOMY 22Q13.3	0.013845363	0.5194247183484401
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.513918735591688
ANIRIDIA 3	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.513918735591688
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
KID SYNDROME	0.013698599999999998	0.513918735591688
REFSUM DISEASE	0.013698599999999998	0.513918735591688
CHOROIDEREMIA	0.013698599999999998	0.513918735591688
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.513918735591688
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
BOUCHER-NEUHAUSER SYNDROME	0.013698599999999998	0.513918735591688
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.513918735591688
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.013698599999999998	0.513918735591688
BASAL LAMINAR DRUSEN	0.013698599999999998	0.513918735591688
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.513918735591688
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.513918735591688
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.513918735591688
BEHR SYNDROME	0.013698599999999998	0.513918735591688
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.513918735591688
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.513918735591688
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.013698599999999998	0.513918735591688
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013510793	0.5068729399647431
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.013510793	0.5068729399647431
RENPENNING SYNDROME 1; RENS1	0.013509959	0.5068416514954482
X SMALL RINGS	0.013401754	0.5027822164594081
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.013397613000000001	0.5026268620812904
DESMOSTEROLOSIS	0.01338824	0.5022752232051495
ISOLATED ECTOPIA LENTIS	0.0133333	0.5002140859113088
CROUZON DISEASE	0.0133333	0.5002140859113088
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.0133333	0.5002140859113088
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0133333	0.5002140859113088
MORNING GLORY DISC ANOMALY	0.0133333	0.5002140859113088
BENCZE SYNDROME	0.0133333	0.5002140859113088
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0133333	0.5002140859113088
SPONDYLOOCULAR SYNDROME; SOS	0.0133333	0.5002140859113088
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.0133333	0.5002140859113088
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0133333	0.5002140859113088
CATARACT 17, MULTIPLE TYPES	0.0133333	0.5002140859113088
MARSHALL SYNDROME	0.0133333	0.5002140859113088
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0133333	0.5002140859113088
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0133333	0.5002140859113088
CATARACT, ANTERIOR POLAR, 2	0.0133333	0.5002140859113088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.013303944	0.4991127618050476
KRABBE DISEASE	0.012969373999999999	0.48656098342135057
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.012965239	0.4864058541401342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012856194000000001	0.4823149055378978
EPIDERMAL NEVUS SYNDROME	0.012719124	0.4771725668253613
2Q23.1 MICRODUPLICATION SYNDROME	0.012719124	0.4771725668253613
16Q24.3 MICRODELETION SYNDROME	0.012714989	0.47701743754414483
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.012654893	0.474762866979699
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4720009279994922
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.012515993	0.46955187371223467
MICROPHTHALMIA, ISOLATED 5	0.01243895	0.46666151694977803
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.01243895	0.46666151694977803
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01242382	0.4660938975967417
SCHWARTZ-JAMPEL SYNDROME	0.01242382	0.4660938975967417
MUCOPOLYSACCHARIDOSIS TYPE 1	0.01242382	0.4660938975967417
MICRO SYNDROME	0.012414873	0.4657582406006006
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.012395433	0.465028926640057
TARP SYNDROME	0.012240173	0.459204169154769
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01217357	0.45670548100075237
X-LINKED RECESSIVE OCULAR ALBINISM	0.01217357	0.45670548100075237
LOWRY-WOOD SYNDROME	0.01217357	0.45670548100075237
OCULAR ALBINISM	0.01217357	0.45670548100075237
PELIZAEUS-MERZBACHER DISEASE	0.012109339	0.45429578115509006
ZELLWEGER SYNDROME	0.012109339	0.45429578115509006
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45168897145609965
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609965
PERLMAN SYNDROME	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45168897145609965
RING CHROMOSOME 14 SYNDROME	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609965
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.45168897145609965
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.45168897145609965
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.011959423	0.4486715099766512
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.011869319	0.4452911547759917
COG5-CDG	0.011869319	0.4452911547759917
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.011694619	0.4387370833301601
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.011518610000000002	0.43213390324367273
EXUDATIVE VITREORETINOPATHY 4	0.011518610000000002	0.43213390324367273
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.43157352450763153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.43157352450763153
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.011503673	0.43157352450763153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.43157352450763153
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011503673	0.43157352450763153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.43157352450763153
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.43157352450763153
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.43157352450763153
PEHO SYNDROME; PEHO	0.011503673	0.43157352450763153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.43157352450763153
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.011503673	0.43157352450763153
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.011503673	0.43157352450763153
HYPEREKPLEXIA 4; HKPX4	0.011503673	0.43157352450763153
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.43157352450763153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.43157352450763153
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.011448504	0.4295037960153872
CORNELIA DE LANGE SYNDROME 1	0.011444369	0.4293486667341707
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.42877283134423333
JACOBSEN SYNDROME	0.011384273	0.4270940961697249
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.011384273	0.4270940961697249
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.011384273	0.4270940961697249
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011384273	0.4270940961697249
GALLOWAY-MOWAT SYNDROME	0.011384273	0.4270940961697249
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.011384273	0.4270940961697249
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.011195973	0.42002980508071475
HELSMOORTEL-VAN DER AA SYNDROME	0.011195973	0.42002980508071475
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.011195973	0.42002980508071475
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0111532	0.4184251267867677
PRIMARY PULMONARY HYPOPLASIA	0.0111532	0.4184251267867677
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.010962254000000001	0.41126156796423907
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.010962254000000001	0.41126156796423907
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.010958119	0.4111064386830226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.4111064386830226
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.010958119	0.4111064386830226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.4111064386830226
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.4111064386830226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.4111064386830226
PITT-HOPKINS-LIKE SYNDROME	0.010958119	0.4111064386830226
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.4111064386830226
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.010958119	0.4111064386830226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.4111064386830226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010958119	0.4111064386830226
DEND SYNDROME	0.010958119	0.4111064386830226
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.4111064386830226
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01090295	0.40903671019077825
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010842854	0.4067821396263324
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010842854	0.4067821396263324
PEDIATRIC-ONSET GRAVES DISEASE	0.010842854	0.4067821396263324
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.010842854	0.4067821396263324
ROIFMAN SYNDROME; RFMN	0.010842854	0.4067821396263324
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.010838719	0.40662701034511595
CORNELIA DE LANGE SYNDROME	0.010838719	0.40662701034511595
MICROFORM HOLOPROSENCEPHALY	0.010838719	0.40662701034511595
LOWRY-MACLEAN SYNDROME	0.010699819	0.40141601707765173
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.010520933	0.39470490302694183
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010520933	0.39470490302694183
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.010520933	0.39470490302694183
SCHINDLER DISEASE, TYPE I	0.010520933	0.39470490302694183
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010520933	0.39470490302694183
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010520933	0.39470490302694183
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010520933	0.39470490302694183
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.010520933	0.39470490302694183
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.010520933	0.39470490302694183
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010520933	0.39470490302694183
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010520933	0.39470490302694183
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.010520933	0.39470490302694183
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.010520933	0.39470490302694183
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010520933	0.39470490302694183
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010520933	0.39470490302694183
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.010520933	0.39470490302694183
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.010520933	0.39470490302694183
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010520933	0.39470490302694183
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.010520933	0.39470490302694183
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.010520933	0.39470490302694183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010520933	0.39470490302694183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.010520933	0.39470490302694183
GAUCHER DISEASE, TYPE II	0.010346233	0.3881508315811103
PROPIONIC ACIDEMIA	0.010346233	0.3881508315811103
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010346233	0.3881508315811103
GENITOPATELLAR SYNDROME	0.010346233	0.3881508315811103
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010346233	0.3881508315811103
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.010346233	0.3881508315811103
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.010346233	0.3881508315811103
JOUBERT SYNDROME WITH RENAL DEFECT	0.010346233	0.3881508315811103
OROFACIODIGITAL SYNDROME TYPE 6	0.010346233	0.3881508315811103
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.010346233	0.3881508315811103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.010346233	0.3881508315811103
JOUBERT SYNDROME	0.010346233	0.3881508315811103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.010346233	0.3881508315811103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.010346233	0.3881508315811103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010346233	0.3881508315811103
48,XXYY SYNDROME	0.010346233	0.3881508315811103
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.010346233	0.3881508315811103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.010346233	0.3881508315811103
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.010346233	0.3881508315811103
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.010346233	0.3881508315811103
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010346233	0.3881508315811103
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.010346233	0.3881508315811103
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010346233	0.3881508315811103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010346233	0.3881508315811103
WIEACKER-WOLFF SYNDROME	0.010346233	0.3881508315811103
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.010346233	0.3881508315811103
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0102973	0.3863150538017235
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0102973	0.3863150538017235
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0102973	0.3863150538017235
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0102973	0.3863150538017235
TEMPLE SYNDROME	0.0102973	0.3863150538017235
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0102973	0.3863150538017235
SILVER-RUSSELL SYNDROME	0.0102973	0.3863150538017235
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0102973	0.3863150538017235
VACTERL/VATER ASSOCIATION	0.0102973	0.3863150538017235
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.0102973	0.3863150538017235
DIAMOND-BLACKFAN ANEMIA 1	0.0102973	0.3863150538017235
YUNIS-VARON SYNDROME	0.0102973	0.3863150538017235
RESTRICTIVE DERMOPATHY, LETHAL	0.0102973	0.3863150538017235
PEMPHIGOID GESTATIONIS	0.0102973	0.3863150538017235
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.010095983	0.3787624149851209
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.010095983	0.3787624149851209
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.010095983	0.3787624149851209
OCULOECTODERMAL SYNDROME; OES	0.010095983	0.3787624149851209
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.010095983	0.3787624149851209
DESANTO-SHINAWI SYNDROME	0.010095983	0.3787624149851209
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.010095983	0.3787624149851209
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.010065483	0.3776181724029924
MULTIPLE SULFATASE DEFICIENCY	0.010065483	0.3776181724029924
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010065483	0.3776181724029924
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.009979514	0.37439294648354937
YOU-HOOVER-FONG SYNDROME; YHFS	0.009979514	0.37439294648354937
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.009979514	0.37439294648354937
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009975379	0.3742378172023329
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.009975379	0.3742378172023329
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.009975379	0.3742378172023329
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.009975379	0.3742378172023329
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009975379	0.3742378172023329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.009975379	0.3742378172023329
WITTEVEEN-KOLK SYNDROME	0.009925353	0.37236103427074063
CHROMOSOME 1P35 DELETION SYNDROME	0.009925353	0.37236103427074063
KOOLEN-DE VRIES SYNDROME; KDVS	0.009925353	0.37236103427074063
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009804814	0.36783887503771784
OROFACIODIGITAL SYNDROME XVI; OFD16	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36783887503771784
JOUBERT SYNDROME 21	0.009804814	0.36783887503771784
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36783887503771784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36783887503771784
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.36783887503771784
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009804814	0.36783887503771784
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36783887503771784
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36783887503771784
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009804814	0.36783887503771784
JOUBERT SYNDROME 23; JBTS23	0.009804814	0.36783887503771784
JOUBERT SYNDROME 33; JBTS33	0.009804814	0.36783887503771784
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.009800679	0.36768374575650137
HYPOPHOSPHATASIA, INFANTILE	0.009800679	0.36768374575650137
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.009800679	0.36768374575650137
RETT SYNDROME; RTT	0.009800679	0.36768374575650137
HYPOADRENOCORTICISM, FAMILIAL	0.009800679	0.36768374575650137
TENORIO SYNDROME; TNORS	0.009800679	0.36768374575650137
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.009800679	0.36768374575650137
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.009800679	0.36768374575650137
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.009800679	0.36768374575650137
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009800679	0.36768374575650137
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.009800679	0.36768374575650137
GLUTAMINE DEFICIENCY, CONGENITAL	0.009800679	0.36768374575650137
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.009800679	0.36768374575650137
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.009746043	0.36563401337233165
DYSTONIA 28, CHILDHOOD-ONSET	0.009554564	0.35845045844172846
BARDET-BIEDL SYNDROME 1; BBS1	0.009554564	0.35845045844172846
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.009554564	0.35845045844172846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009554564	0.35845045844172846
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009554564	0.35845045844172846
OKAMOTO SYNDROME	0.009554564	0.35845045844172846
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.009554564	0.35845045844172846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.009554564	0.35845045844172846
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.009554564	0.35845045844172846
9Q33.3Q34.11 MICRODELETION SYNDROME	0.009550429	0.358295329160512
7Q11.23 MICRODUPLICATION SYNDROME	0.009550429	0.358295329160512
SANJAD-SAKATI SYNDROME	0.009550429	0.358295329160512
PITT-HOPKINS SYNDROME	0.009550429	0.358295329160512
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.009550429	0.358295329160512
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.009524064	0.3573062158595999
PEROXISOME BIOGENESIS DISORDER 6B	0.009524064	0.3573062158595999
PEROXISOME BIOGENESIS DISORDER 5B	0.009524064	0.3573062158595999
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009490333	0.35604075859606615
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35604075859606615
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.35604075859606615
KAGAMI-OGATA SYNDROME	0.009490333	0.35604075859606615
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.35604075859606615
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009490333	0.35604075859606615
FG SYNDROME TYPE 1	0.009490333	0.35604075859606615
KAGAMI-OGATA SYNDROME	0.009490333	0.35604075859606615
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.35604075859606615
INFANTILE SIALIC ACID STORAGE DISEASE	0.009490333	0.35604075859606615
POSTERIOR CORTICAL ATROPHY	0.00943396	0.35392586065894044
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00943396	0.35392586065894044
SUDANOPHILIC CEREBRAL SCLEROSIS	0.00943396	0.35392586065894044
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00943396	0.35392586065894044
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.009383934	0.35204907772734817
COCKAYNE SYNDROME A; CSA	0.009379799	0.3518939484461317
WOLCOTT-RALLISON SYNDROME	0.009379799	0.3518939484461317
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.009351433	0.3508297653286019
WYBURN-MASON SYNDROME	0.009351433	0.3508297653286019
PFEIFFER SYNDROME TYPE 2	0.009351433	0.3508297653286019
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.009351433	0.3508297653286019
SRD5A3-CDG	0.009351433	0.3508297653286019
SEVERE CANAVAN DISEASE	0.009351433	0.3508297653286019
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009351433	0.3508297653286019
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009351433	0.3508297653286019
RAVINE SYNDROME	0.00925926	0.3473717892131089
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.3473717892131089
STUVE-WIEDEMANN SYNDROME	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
AORTIC ARCH DEFECTS	0.00925926	0.3473717892131089
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00925926	0.3473717892131089
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00925926	0.3473717892131089
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00925926	0.3473717892131089
SHPRINTZEN-GOLDBERG SYNDROME	0.00925926	0.3473717892131089
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.3473717892131089
BUTYRYLCHOLINESTERASE	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
PAINE SYNDROME	0.00925926	0.3473717892131089
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00925926	0.3473717892131089
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 3	0.00925926	0.3473717892131089
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.3473717892131089
LARYNGOTRACHEAL ANGIOMA	0.00925926	0.3473717892131089
CAMPOMELIC DYSPLASIA	0.00925926	0.3473717892131089
RETINITIS PIGMENTOSA 27; RP27	0.009188660000000001	0.34472314900660805
CHROMOSOME XP11.3 DELETION SYNDROME	0.009188660000000001	0.34472314900660805
SIFRIM-HITZ-WEISS SYNDROME	0.00900901	0.3379833726171195
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.3379833726171195
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00900901	0.3379833726171195
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00900901	0.3379833726171195
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00900901	0.3379833726171195
VAN BOGAERT-HOZAY SYNDROME	0.00900901	0.3379833726171195
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00900901	0.3379833726171195
ERMINE PHENOTYPE	0.00900901	0.3379833726171195
HYPEREKPLEXIA 2; HKPX2	0.00900901	0.3379833726171195
BRANCHIOGENIC DEAFNESS SYNDROME	0.00900901	0.3379833726171195
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00900901	0.3379833726171195
HYDRANENCEPHALY	0.009005013000000001	0.3378334205646354
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00897851	0.336839130034991
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.3357288020526737
ROBERTS SYNDROME	0.008948914	0.3357288020526737
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3357288020526737
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.3357288020526737
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3355736727714572
ADAMS-OLIVER SYNDROME	0.008944779	0.3355736727714572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
OLIVER SYNDROME	0.00893619	0.3352514465570998
DUBOWITZ SYNDROME	0.00883838	0.33158199190273924
FONTAINE PROGEROID SYNDROME; FPS	0.00883838	0.33158199190273924
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00883838	0.33158199190273924
16P12.1P12.3 TRIPLICATION SYNDROME	0.00883838	0.33158199190273924
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.008810014	0.3305178087852094
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.008810014	0.3305178087852094
KNOBLOCH SYNDROME 1; KNO1	0.008805878999999999	0.33036267950399295
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.008805878999999999	0.33036267950399295
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.008805878999999999	0.33036267950399295
GLIOBLASTOMA	0.008805878999999999	0.33036267950399295
TYROSINEMIA TYPE 2	0.008805878999999999	0.33036267950399295
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.008805878999999999	0.33036267950399295
NEURONAL CEROID LIPOFUSCINOSIS	0.008805878999999999	0.33036267950399295
ECTODERMAL DYSPLASIA SYNDROME	0.008805878999999999	0.33036267950399295
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.008794863	0.3299494015930183
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00865907	0.32485497100433025
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00865907	0.32485497100433025
BLUE CONE MONOCHROMACY; BCM	0.00865907	0.32485497100433025
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00865907	0.32485497100433025
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00865907	0.32485497100433025
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00865907	0.32485497100433025
CONE DYSTROPHY 4	0.00865907	0.32485497100433025
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00865907	0.32485497100433025
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00865907	0.32485497100433025
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00865907	0.32485497100433025
8Q24.3 MICRODELETION SYNDROME	0.008475423000000001	0.3179652425623576
ISOLATED COMPLEX I DEFICIENCY	0.008463594000000001	0.3175214640212429
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.31526171622806476
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31526171622806476
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
NEMALINE MYOPATHY 10	0.00840336	0.31526171622806476
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
RENAL TUBULAR DYSGENESIS	0.00840336	0.31526171622806476
SCHISIS ASSOCIATION	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
FATCO SYNDROME	0.00840336	0.31526171622806476
HYDROLETHALUS	0.00840336	0.31526171622806476
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806476
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.31526171622806476
TEMPLE SYNDROME	0.00840336	0.31526171622806476
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.31526171622806476
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.31526171622806476
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.31526171622806476
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.31526171622806476
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.31526171622806476
GMS SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
EBSTEIN MALFORMATION	0.00840336	0.31526171622806476
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.31526171622806476
CONGENITAL ANALBUMINEMIA	0.00840336	0.31526171622806476
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31526171622806476
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
DISTAL MONOSOMY 17Q	0.00840336	0.31526171622806476
BLAU SYNDROME	0.00826446	0.3100507229606005
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.3100507229606005
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.3100507229606005
LEBER OPTIC ATROPHY AND DYSTONIA	0.00826446	0.3100507229606005
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00826446	0.3100507229606005
WEILL-MARCHESANI SYNDROME	0.00826446	0.3100507229606005
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.3100507229606005
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.3100507229606005
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00826446	0.3100507229606005
ISOLATED ANIRIDIA	0.00826446	0.3100507229606005
X-LINKED CORNEAL DERMOID	0.00826446	0.3100507229606005
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00826446	0.3100507229606005
VON HIPPEL-LINDAU DISEASE	0.00826446	0.3100507229606005
BRITTLE CORNEA SYNDROME	0.00826446	0.3100507229606005
SPONDYLO-OCULAR SYNDROME	0.00826446	0.3100507229606005
CONGENITAL GLAUCOMA	0.00826446	0.3100507229606005
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.3100507229606005
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.3100507229606005
NEUROMYELITIS OPTICA	0.00826446	0.3100507229606005
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00826446	0.3100507229606005
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00826446	0.3100507229606005
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.3100507229606005
STICKLER SYNDROME TYPE 1	0.00826446	0.3100507229606005
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00826446	0.3100507229606005
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00826446	0.3100507229606005
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.3100507229606005
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.3100507229606005
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00826446	0.3100507229606005
LCAT DEFICIENCY	0.00826446	0.3100507229606005
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00826446	0.3100507229606005
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.3100507229606005
CUSHING DISEASE	0.00826446	0.3100507229606005
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.3100507229606005
CATARACT 44; CTRCT44	0.00826446	0.3100507229606005
PEROXISOME BIOGENESIS DISORDER 11B	0.00826446	0.3100507229606005
NANCE-HORAN SYNDROME	0.00826446	0.3100507229606005
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.3100507229606005
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.3100507229606005
NANCE-HORAN SYNDROME	0.00826446	0.3100507229606005
SUSAC SYNDROME	0.00826446	0.3100507229606005
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00826446	0.3100507229606005
15Q OVERGROWTH SYNDROME	0.008249309	0.30948231576840934
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.008249309	0.30948231576840934
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008249309	0.30948231576840934
DILATED CARDIOMYOPATHY WITH ATAXIA	0.008249309	0.30948231576840934
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.008031413	0.3013076966970819
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.008031413	0.3013076966970819
MAN1B1-CDG	0.008031413	0.3013076966970819
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.008031413	0.3013076966970819
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.008031413	0.3013076966970819
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.008031413	0.3013076966970819
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00770789	0.28917035922501694
TRISOMY 18P	0.00770789	0.28917035922501694
W SYNDROME	0.007587804	0.28466519480804997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28466519480804997
1Q44 MICRODELETION SYNDROME	0.007587804	0.28466519480804997
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28466519480804997
PELGER-HUET ANOMALY; PHA	0.007587804	0.28466519480804997
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28466519480804997
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28466519480804997
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
JOUBERT SYNDROME 24	0.007489994	0.2809957401536894
AARSKOG-SCOTT SYNDROME	0.007489994	0.2809957401536894
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007489994	0.2809957401536894
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.007489994	0.2809957401536894
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.007489994	0.2809957401536894
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.007489994	0.2809957401536894
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007489994	0.2809957401536894
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.007489994	0.2809957401536894
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007489994	0.2809957401536894
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.007489994	0.2809957401536894
COFFIN-SIRIS SYNDROME 7; CSS7	0.007489994	0.2809957401536894
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007489994	0.2809957401536894
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.007489994	0.2809957401536894
XP22.13P22.2 DUPLICATION SYNDROME	0.007485858999999999	0.280840610872473
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.007485858999999999	0.280840610872473
IMMUNODEFICIENCY 47	0.007485858999999999	0.280840610872473
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.007485858999999999	0.280840610872473
MENTAL RETARDATION, X-LINKED 1	0.007485858999999999	0.280840610872473
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007485858999999999	0.280840610872473
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.007485858999999999	0.280840610872473
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.007111073000000001	0.26678008299097666
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.007111073000000001	0.26678008299097666
WEBB-DATTANI SYNDROME; WEDAS	0.007111073000000001	0.26678008299097666
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007111073000000001	0.26678008299097666
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.007111073000000001	0.26678008299097666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007111073000000001	0.26678008299097666
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.007111073000000001	0.26678008299097666
GM2-GANGLIOSIDOSIS, AB VARIANT	0.007111073000000001	0.26678008299097666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.007111073000000001	0.26678008299097666
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.007111073000000001	0.26678008299097666
CANAVAN DISEASE	0.007111073000000001	0.26678008299097666
TAY-SACHS DISEASE	0.007111073000000001	0.26678008299097666
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.007111073000000001	0.26678008299097666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.007111073000000001	0.26678008299097666
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
AMISH LETHAL MICROCEPHALY	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26419810898344104
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00694444	0.26052865432908046
9P13 MICRODELETION SYNDROME	0.00694444	0.26052865432908046
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00694444	0.26052865432908046
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00694444	0.26052865432908046
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.00694444	0.26052865432908046
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00694444	0.26052865432908046
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00694444	0.26052865432908046
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00694444	0.26052865432908046
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00694444	0.26052865432908046
BRACHYDACTYLY, TYPE B2	0.00694444	0.26052865432908046
CRANIOECTODERMAL DYSPLASIA 4	0.00694444	0.26052865432908046
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00694444	0.26052865432908046
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00694444	0.26052865432908046
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00694444	0.26052865432908046
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00694444	0.26052865432908046
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00694444	0.26052865432908046
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00694444	0.26052865432908046
FLOATING-HARBOR SYNDROME	0.00694444	0.26052865432908046
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00694444	0.26052865432908046
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00694444	0.26052865432908046
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00694444	0.26052865432908046
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00694444	0.26052865432908046
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00694444	0.26052865432908046
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006900923	0.25889606401935955
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.006900923	0.25889606401935955
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.006900923	0.25889606401935955
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.006900923	0.25889606401935955
XQ28 (MECP2) DUPLICATION	0.006900923	0.25889606401935955
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006900923	0.25889606401935955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006900923	0.25889606401935955
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.006900923	0.25889606401935955
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.006900923	0.25889606401935955
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.006900923	0.25889606401935955
MONOSOMY 18Q	0.006900923	0.25889606401935955
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006900923	0.25889606401935955
TETRASOMY 5P	0.006900923	0.25889606401935955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.006900923	0.25889606401935955
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.006581483000000001	0.24691190498869886
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.006581483000000001	0.24691190498869886
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.006581483000000001	0.24691190498869886
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.006581483000000001	0.24691190498869886
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.006569654000000001	0.24646812644758417
JOUBERT SYNDROME 6	0.006569654000000001	0.24646812644758417
LIGNEOUS CONJUNCTIVITIS	0.006569654000000001	0.24646812644758417
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006569654000000001	0.24646812644758417
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.006569654000000001	0.24646812644758417
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.006569654000000001	0.24646812644758417
ARIMA SYNDROME	0.006569654000000001	0.24646812644758417
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006569654000000001	0.24646812644758417
SANDHOFF DISEASE	0.0065655190000000006	0.2463129971663677
MOMO SYNDROME	0.0065655190000000006	0.2463129971663677
KRABBE DISEASE	0.0065655190000000006	0.2463129971663677
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0065655190000000006	0.2463129971663677
BEHÇET DISEASE	0.0065655190000000006	0.2463129971663677
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0065655190000000006	0.2463129971663677
NORRIE DISEASE	0.0065655190000000006	0.2463129971663677
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0065655190000000006	0.2463129971663677
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.0065655190000000006	0.2463129971663677
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0065655190000000006	0.2463129971663677
TAY-SACHS DISEASE; TSD	0.0065655190000000006	0.2463129971663677
GM1 GANGLIOSIDOSIS	0.0065655190000000006	0.2463129971663677
MICROPHTHALMIA, SYNDROMIC 1	0.0065655190000000006	0.2463129971663677
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0065655190000000006	0.2463129971663677
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.006359504	0.2385841074759671
HYPOTONIA-CYSTINURIA SYNDROME	0.006359504	0.2385841074759671
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006359504	0.2385841074759671
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.006359504	0.2385841074759671
HARTSFIELD SYNDROME; HRTFDS	0.006359504	0.2385841074759671
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.006359504	0.2385841074759671
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.006359504	0.2385841074759671
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.006359504	0.2385841074759671
ALAZAMI-YUAN SYNDROME	0.006359504	0.2385841074759671
ZEBRA BODY MYOPATHY	0.006359504	0.2385841074759671
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.006359504	0.2385841074759671
47,XYY SYNDROME	0.006355369	0.23842897819475062
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.006355369	0.23842897819475062
1Q41Q42 MICRODELETION SYNDROME	0.006355369	0.23842897819475062
MALAN OVERGROWTH SYNDROME	0.006355369	0.23842897819475062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.006355369	0.23842897819475062
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006355369	0.23842897819475062
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.006355369	0.23842897819475062
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.006355369	0.23842897819475062
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.006355369	0.23842897819475062
RETT SYNDROME, CONGENITAL VARIANT	0.006355369	0.23842897819475062
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.006145473	0.23055448832529296
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.006145473	0.23055448832529296
COFFIN-SIRIS SYNDROME 4; CSS4	0.006145473	0.23055448832529296
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.006145473	0.23055448832529296
COFFIN-SIRIS SYNDROME 3; CSS3	0.006145473	0.23055448832529296
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.006145473	0.23055448832529296
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.006040064	0.2265999484453064
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006040064	0.2265999484453064
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.006040064	0.2265999484453064
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.006040064	0.2265999484453064
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.006040064	0.2265999484453064
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006035929000000001	0.22644481916408993
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006035929000000001	0.22644481916408993
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006035929000000001	0.22644481916408993
EPISODIC ATAXIA TYPE 6	0.006035929000000001	0.22644481916408993
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.006035929000000001	0.22644481916408993
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.006035929000000001	0.22644481916408993
20P13 MICRODELETION SYNDROME	0.006035929000000001	0.22644481916408993
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.006024100000000001	0.22600104062297524
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.006024100000000001	0.22600104062297524
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.006024100000000001	0.22600104062297524
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.006024100000000001	0.22600104062297524
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.006024100000000001	0.22600104062297524
WEILL-MARCHESANI SYNDROME 1; WMS1	0.006024100000000001	0.22600104062297524
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.006024100000000001	0.22600104062297524
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006024100000000001	0.22600104062297524
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.006024100000000001	0.22600104062297524
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006024100000000001	0.22600104062297524
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.006024100000000001	0.22600104062297524
MUSK, INABILITY TO SMELL	0.006024100000000001	0.22600104062297524
CYSTINOSIS, NEPHROPATHIC; CTNS	0.006024100000000001	0.22600104062297524
RETINITIS PIGMENTOSA 35; RP35	0.006024100000000001	0.22600104062297524
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.006024100000000001	0.22600104062297524
EHLERS-DANLOS SYNDROME, TYPE VI	0.006024100000000001	0.22600104062297524
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.006024100000000001	0.22600104062297524
FLECK RETINA OF KANDORI	0.006024100000000001	0.22600104062297524
FREESIA FLOWERS, INABILITY TO SMELL	0.006024100000000001	0.22600104062297524
STICKLER SYNDROME, TYPE I	0.006024100000000001	0.22600104062297524
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.006024100000000001	0.22600104062297524
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.006024100000000001	0.22600104062297524
FRASER SYNDROME	0.006024100000000001	0.22600104062297524
RETINITIS PIGMENTOSA 29; RP29	0.006024100000000001	0.22600104062297524
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.006024100000000001	0.22600104062297524
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.006024100000000001	0.22600104062297524
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.006024100000000001	0.22600104062297524
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.006024100000000001	0.22600104062297524
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.006024100000000001	0.22600104062297524
SANDHOFF DISEASE	0.006024100000000001	0.22600104062297524
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.006024100000000001	0.22600104062297524
RODRIGUES BLINDNESS	0.006024100000000001	0.22600104062297524
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.006024100000000001	0.22600104062297524
TEMPORAL ARTERITIS	0.006024100000000001	0.22600104062297524
VITREORETINOCHOROIDOPATHY; VRCP	0.006024100000000001	0.22600104062297524
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.006024100000000001	0.22600104062297524
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.006024100000000001	0.22600104062297524
IDIOPATHIC PANUVEITIS	0.006024100000000001	0.22600104062297524
SORSBY FUNDUS DYSTROPHY; SFD	0.006024100000000001	0.22600104062297524
LEBER CONGENITAL AMAUROSIS, TYPE I	0.006024100000000001	0.22600104062297524
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.006024100000000001	0.22600104062297524
LEBER CONGENITAL AMAUROSIS, TYPE II	0.006024100000000001	0.22600104062297524
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.006024100000000001	0.22600104062297524
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.006024100000000001	0.22600104062297524
NON-24-HOUR SLEEP-WAKE SYNDROME	0.006024100000000001	0.22600104062297524
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.006024100000000001	0.22600104062297524
USHER SYNDROME, TYPE IID; USH2D	0.006024100000000001	0.22600104062297524
COGAN SYNDROME	0.006024100000000001	0.22600104062297524
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.006024100000000001	0.22600104062297524
MUCOUS MEMBRANE PEMPHIGOID	0.006024100000000001	0.22600104062297524
WEILL-MARCHESANI SYNDROME 2; WMS2	0.006024100000000001	0.22600104062297524
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.006024100000000001	0.22600104062297524
CEREBROOCULONASAL SYNDROME	0.006024100000000001	0.22600104062297524
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.006024100000000001	0.22600104062297524
RETINITIS PIGMENTOSA	0.006024100000000001	0.22600104062297524
PIERSON SYNDROME	0.006024100000000001	0.22600104062297524
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.006024100000000001	0.22600104062297524
SARCOIDOSIS	0.006024100000000001	0.22600104062297524
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.006024100000000001	0.22600104062297524
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.006024100000000001	0.22600104062297524
RETINITIS PIGMENTOSA 71; RP71	0.006024100000000001	0.22600104062297524
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00581395	0.21811702165135816
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00581395	0.21811702165135816
GERMAN SYNDROME	0.00581395	0.21811702165135816
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00581395	0.21811702165135816
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00581395	0.21811702165135816
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00581395	0.21811702165135816
EMERY-NELSON SYNDROME	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00581395	0.21811702165135816
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00581395	0.21811702165135816
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00581395	0.21811702165135816
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00581395	0.21811702165135816
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00581395	0.21811702165135816
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00581395	0.21811702165135816
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00581395	0.21811702165135816
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00581395	0.21811702165135816
FG SYNDROME 2; FGS2	0.00581395	0.21811702165135816
LOEYS-DIETZ SYNDROME 5	0.00581395	0.21811702165135816
BETHLEM MYOPATHY	0.00581395	0.21811702165135816
AMISH NEMALINE MYOPATHY	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00581395	0.21811702165135816
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00581395	0.21811702165135816
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00581395	0.21811702165135816
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00581395	0.21811702165135816
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00581395	0.21811702165135816
TYPICAL NEMALINE MYOPATHY	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00581395	0.21811702165135816
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00581395	0.21811702165135816
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00581395	0.21811702165135816
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00581395	0.21811702165135816
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00581395	0.21811702165135816
RADICULONEUROPATHY, FATAL NEONATAL	0.00581395	0.21811702165135816
MYOPATHY AND DIABETES MELLITUS	0.00581395	0.21811702165135816
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00581395	0.21811702165135816
BETHLEM MYOPATHY 1	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00581395	0.21811702165135816
NEMALINE MYOPATHY 3; NEM3	0.00581395	0.21811702165135816
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00581395	0.21811702165135816
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00581395	0.21811702165135816
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00581395	0.21811702165135816
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.005604054	0.21024253178190047
PETERS PLUS SYNDROME	0.005604054	0.21024253178190047
2P15P16.1 MICRODELETION SYNDROME	0.005604054	0.21024253178190047
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005604054	0.21024253178190047
FILIPPI SYNDROME; FLPIS	0.005599919	0.21008740250068403
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.005599919	0.21008740250068403
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.005599919	0.21008740250068403
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.005599919	0.21008740250068403
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.005599919	0.21008740250068403
COFS SYNDROME	0.005599919	0.21008740250068403
CONGENITAL RUBELLA SYNDROME	0.005599919	0.21008740250068403
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.005599919	0.21008740250068403
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00549451	0.20613286262069747
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00549451	0.20613286262069747
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00549451	0.20613286262069747
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00549451	0.20613286262069747
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00549451	0.20613286262069747
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00549451	0.20613286262069747
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA 85; RP85	0.00549451	0.20613286262069747
SPINOCEREBELLAR ATAXIA TYPE 25	0.00549451	0.20613286262069747
CORNEAL DYSTROPHY, MEESMANN	0.00549451	0.20613286262069747
INTERMEDIATE UVEITIS	0.00549451	0.20613286262069747
IRVAN SYNDROME	0.00549451	0.20613286262069747
STARGARDT DISEASE 3; STGD3	0.00549451	0.20613286262069747
MADRAS MOTOR NEURON DISEASE	0.00549451	0.20613286262069747
OCULOCUTANEOUS ALBINISM TYPE 5	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA 77; RP77	0.00549451	0.20613286262069747
KERATOCONUS 9; KTCN9	0.00549451	0.20613286262069747
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00549451	0.20613286262069747
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00549451	0.20613286262069747
OCULOCUTANEOUS ALBINISM TYPE 6	0.00549451	0.20613286262069747
COLOBOMA, OCULAR	0.00549451	0.20613286262069747
PRIMARY HYPEROXALURIA	0.00549451	0.20613286262069747
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00549451	0.20613286262069747
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00549451	0.20613286262069747
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00549451	0.20613286262069747
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00549451	0.20613286262069747
FOCAL DERMAL HYPOPLASIA; FDH	0.00549451	0.20613286262069747
DERMOCHONDROCORNEAL DYSTROPHY	0.00549451	0.20613286262069747
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00549451	0.20613286262069747
FRIEDREICH ATAXIA	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA 60; RP60	0.00549451	0.20613286262069747
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00549451	0.20613286262069747
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00549451	0.20613286262069747
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00549451	0.20613286262069747
PSEUDOXANTHOMA ELASTICUM; PXE	0.00549451	0.20613286262069747
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00549451	0.20613286262069747
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00549451	0.20613286262069747
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00549451	0.20613286262069747
CONE-ROD DYSTROPHY 5; CORD5	0.00549451	0.20613286262069747
RETINOBLASTOMA	0.00549451	0.20613286262069747
NANOPHTHALMOS 4; NNO4	0.00549451	0.20613286262069747
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00549451	0.20613286262069747
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00549451	0.20613286262069747
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00549451	0.20613286262069747
RAMOS-ARROYO SYNDROME	0.00549451	0.20613286262069747
LEBER CONGENITAL AMAUROSIS 16	0.00549451	0.20613286262069747
CONE-ROD DYSTROPHY 21; CORD21	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00549451	0.20613286262069747
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA 56; RP56	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA 76; RP76	0.00549451	0.20613286262069747
RETINITIS PIGMENTOSA 51; RP51	0.00549451	0.20613286262069747
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00549451	0.20613286262069747
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00549451	0.20613286262069747
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00549451	0.20613286262069747
FOVEAL HYPOPLASIA 2; FVH2	0.00549451	0.20613286262069747
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00549451	0.20613286262069747
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0050585	0.18977544595729154
OSTEOGENESIS IMPERFECTA	0.0050585	0.18977544595729154
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.004251533	0.1595011507516342
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004251533	0.1595011507516342
COFFIN-SIRIS SYNDROME 2; CSS2	0.004251533	0.1595011507516342
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004251533	0.1595011507516342
INCONTINENTIA PIGMENTI	0.004251533	0.1595011507516342
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.1595011507516342
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004251533	0.1595011507516342
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004251533	0.1595011507516342
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.1595011507516342
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.1595011507516342
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.1595011507516342
RFT1-CDG	0.004251533	0.1595011507516342
JABERI-ELAHI SYNDROME; JABELS	0.004251533	0.1595011507516342
HEART AND BRAIN MALFORMATION SYNDROME	0.004251533	0.1595011507516342
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.1595011507516342
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004251533	0.1595011507516342
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004251533	0.1595011507516342
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.1595011507516342
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.1595011507516342
CRANIOTELENCEPHALIC DYSPLASIA	0.0037101139999999996	0.13918919420824172
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0037101139999999996	0.13918919420824172
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.13918919420824172
TREACHER-COLLINS SYNDROME	0.0037101139999999996	0.13918919420824172
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0037101139999999996	0.13918919420824172
HYPERTRYPTOPHANEMIA; HYPTRP	0.0037101139999999996	0.13918919420824172
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.13918919420824172
N SYNDROME	0.0037101139999999996	0.13918919420824172
ABLEPHARON MACROSTOMIA SYNDROME	0.0037101139999999996	0.13918919420824172
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.13918919420824172
MUCOLIPIDOSIS IV; ML4	0.0037101139999999996	0.13918919420824172
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0037101139999999996	0.13918919420824172
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.13918919420824172
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.13903406492702527
TRIPLE A SYNDROME	0.003705979	0.13903406492702527
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003705979	0.13903406492702527
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003705979	0.13903406492702527
MUSCLE-EYE-BRAIN DISEASE	0.003705979	0.13903406492702527
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003705979	0.13903406492702527
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.003705979	0.13903406492702527
PAPILLOMA OF CHOROID PLEXUS	0.003705979	0.13903406492702527
INFANTILE NEUROAXONAL DYSTROPHY	0.003705979	0.13903406492702527
NEONATAL ADRENOLEUKODYSTROPHY	0.003705979	0.13903406492702527
CADASIL	0.003705979	0.13903406492702527
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.003705979	0.13903406492702527
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.003705979	0.13903406492702527
FOUNTAIN SYNDROME	0.003705979	0.13903406492702527
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.13903406492702527
FLYNN-AIRD SYNDROME	0.003705979	0.13903406492702527
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.13903406492702527
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.003705979	0.13903406492702527
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.003705979	0.13903406492702527
KALLMANN SYNDROME	0.003705979	0.13903406492702527
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.003705979	0.13903406492702527
ERDHEIM-CHESTER DISEASE	0.00316456	0.11872210838363281
MALT LYMPHOMA	0.00316456	0.11872210838363281
BLUE CONE MONOCHROMATISM	0.00316456	0.11872210838363281
X-LINKED RETINAL DYSPLASIA	0.00316456	0.11872210838363281
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11872210838363281
CONE ROD DYSTROPHY	0.00316456	0.11872210838363281
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11872210838363281
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11872210838363281
FISH-EYE DISEASE	0.00316456	0.11872210838363281
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11872210838363281
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11872210838363281
BRADYOPSIA	0.00316456	0.11872210838363281
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11872210838363281
PROLIDASE DEFICIENCY	0.00316456	0.11872210838363281
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11872210838363281
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.11872210838363281
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11872210838363281
GOLDENHAR SYNDROME	0.00316456	0.11872210838363281
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11872210838363281
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00316456	0.11872210838363281
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.11872210838363281
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11872210838363281
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11872210838363281
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11872210838363281
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11872210838363281
ALBINISM, OCULAR, TYPE I	0.00316456	0.11872210838363281
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.11872210838363281
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.11872210838363281
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00316456	0.11872210838363281
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11872210838363281
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11872210838363281
JALILI SYNDROME	0.00316456	0.11872210838363281
MARFAN SYNDROME	0.00316456	0.11872210838363281
TANGIER DISEASE; TGD	0.00316456	0.11872210838363281
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11872210838363281
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.11872210838363281
MANGANESE POISONING	0.00316456	0.11872210838363281
BUSCHKE-OLLENDORFF SYNDROME	0.00316456	0.11872210838363281
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00316456	0.11872210838363281
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11872210838363281
SPASTIC PARAPLEGIA 16, X-LINKED	0.00316456	0.11872210838363281
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11872210838363281
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.11872210838363281
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363281
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363281
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11872210838363281
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11872210838363281
CHYLOMICRON RETENTION DISEASE	0.00316456	0.11872210838363281
CYSTINOSIS	0.00316456	0.11872210838363281
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11872210838363281
APERT SYNDROME	0.00316456	0.11872210838363281
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.11872210838363281
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.11872210838363281
MOEBIUS SYNDROME	0.00316456	0.11872210838363281
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00316456	0.11872210838363281
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.11872210838363281
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11872210838363281
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11872210838363281
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11872210838363281
N SYNDROME	0.00316456	0.11872210838363281
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00316456	0.11872210838363281
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11872210838363281
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00316456	0.11872210838363281
ASCHER SYNDROME	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.11872210838363281
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.11872210838363281
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.11872210838363281
BETA-THALASSEMIA MAJOR	0.00316456	0.11872210838363281
WAGR SYNDROME	0.00316456	0.11872210838363281
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00316456	0.11872210838363281
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11872210838363281
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.11872210838363281
MUCOLIPIDOSIS TYPE III	0.00316456	0.11872210838363281
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11872210838363281
HALLERMANN-STREIFF SYNDROME	0.00316456	0.11872210838363281
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11872210838363281
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.11872210838363281
RENAL COLOBOMA SYNDROME	0.00316456	0.11872210838363281
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11872210838363281
MMEP SYNDROME	0.00316456	0.11872210838363281
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.11872210838363281
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.11872210838363281
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11872210838363281
FETAL METHYLMERCURY SYNDROME	0.00316456	0.11872210838363281
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.11872210838363281
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11872210838363281
GILLESPIE SYNDROME; GLSP	0.00316456	0.11872210838363281
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11872210838363281
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00316456	0.11872210838363281
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11872210838363281
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11872210838363281
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11872210838363281
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11872210838363281
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11872210838363281
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.11872210838363281
GAPO SYNDROME	0.00316456	0.11872210838363281
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11872210838363281
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11872210838363281
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11872210838363281
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11872210838363281
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11872210838363281
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11872210838363281
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.11872210838363281
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11872210838363281
ABETALIPOPROTEINEMIA	0.00316456	0.11872210838363281
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11872210838363281
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00316456	0.11872210838363281
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002980913	0.11183237994166013
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.002980913	0.11183237994166013
EMANUEL SYNDROME	0.002980913	0.11183237994166013
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002980913	0.11183237994166013
LATHOSTEROLOSIS	0.002980913	0.11183237994166013
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002980913	0.11183237994166013
DISTAL MONOSOMY 15Q	0.002980913	0.11183237994166013
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002980913	0.11183237994166013
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002980913	0.11183237994166013
PALLISTER-HALL SYNDROME	0.002980913	0.11183237994166013
COFFIN-SIRIS SYNDROME	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002980913	0.11183237994166013
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002980913	0.11183237994166013
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002980913	0.11183237994166013
AL KAISSI SYNDROME; ALKAS	0.002980913	0.11183237994166013
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002980913	0.11183237994166013
BOHRING-OPITZ SYNDROME	0.002980913	0.11183237994166013
8P23.1 MICRODELETION SYNDROME	0.002980913	0.11183237994166013
CATEL-MANZKE SYNDROME; CATMANS	0.002980913	0.11183237994166013
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.002980913	0.11183237994166013
COHEN SYNDROME	0.002980913	0.11183237994166013
WOLF-HIRSCHHORN SYNDROME	0.002980913	0.11183237994166013
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.002980913	0.11183237994166013
AICARDI-GOUTIERES SYNDROME 7	0.002980913	0.11183237994166013
15Q24 MICRODELETION SYNDROME	0.002980913	0.11183237994166013
PETERS-PLUS SYNDROME; PTRPLS	0.002980913	0.11183237994166013
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002980913	0.11183237994166013
COFFIN-SIRIS SYNDROME 5	0.002980913	0.11183237994166013
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002980913	0.11183237994166013
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002980913	0.11183237994166013
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002980913	0.11183237994166013
FILIPPI SYNDROME	0.002980913	0.11183237994166013
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002980913	0.11183237994166013
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002980913	0.11183237994166013
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002980913	0.11183237994166013
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.002980913	0.11183237994166013
MATERNAL PHENYLKETONURIA	0.002980913	0.11183237994166013
22Q11.2 DELETION SYNDROME	0.002980913	0.11183237994166013
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002980913	0.11183237994166013
SMITH-LEMLI-OPITZ SYNDROME	0.002980913	0.11183237994166013
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002980913	0.11183237994166013
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.002980913	0.11183237994166013
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.002980913	0.11183237994166013
RUVALCABA SYNDROME	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.002980913	0.11183237994166013
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002980913	0.11183237994166013
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.002980913	0.11183237994166013
BOHRING-OPITZ SYNDROME	0.002980913	0.11183237994166013
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002980913	0.11183237994166013
MACDERMOT-WINTER SYNDROME	0.002980913	0.11183237994166013
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002980913	0.11183237994166013
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002980913	0.11183237994166013
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.002980913	0.11183237994166013
STT3B-CDG	0.002980913	0.11183237994166013
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002980913	0.11183237994166013
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.002980913	0.11183237994166013
19P13.12 MICRODELETION SYNDROME	0.002980913	0.11183237994166013
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.002439494	0.09152042339826766
DE BARSY SYNDROME	0.002439494	0.09152042339826766
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002439494	0.09152042339826766
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002439494	0.09152042339826766
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.002439494	0.09152042339826766
RITSCHER-SCHINZEL SYNDROME 1	0.002439494	0.09152042339826766
TRISOMY 17P	0.002439494	0.09152042339826766
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.002439494	0.09152042339826766
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.002439494	0.09152042339826766
XQ27.3Q28 DUPLICATION SYNDROME	0.002439494	0.09152042339826766
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002439494	0.09152042339826766
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002439494	0.09152042339826766
DIAPHANOSPONDYLODYSOSTOSIS	0.002439494	0.09152042339826766
OROFACIODIGITAL SYNDROME TYPE 4	0.002439494	0.09152042339826766
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.002439494	0.09152042339826766
EAR-PATELLA-SHORT STATURE SYNDROME	0.002439494	0.09152042339826766
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002439494	0.09152042339826766
12Q14 MICRODELETION SYNDROME	0.002439494	0.09152042339826766
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.002439494	0.09152042339826766
SECKEL SYNDROME 9; SCKL9	0.002439494	0.09152042339826766
LOWRY-MACLEAN SYNDROME	0.002439494	0.09152042339826766
OCULO-PALATO-CEREBRAL SYNDROME	0.002439494	0.09152042339826766
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.002439494	0.09152042339826766
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002439494	0.09152042339826766
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.002439494	0.09152042339826766
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002439494	0.09152042339826766
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002439494	0.09152042339826766
MARDEN-WALKER SYNDROME	0.002439494	0.09152042339826766
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.002439494	0.09152042339826766
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002439494	0.09152042339826766
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002439494	0.09152042339826766
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002439494	0.09152042339826766
CONGENITAL VARICELLA SYNDROME	0.002439494	0.09152042339826766
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002439494	0.09152042339826766
TARP SYNDROME; TARPS	0.002439494	0.09152042339826766
%300712 CRANIOFACIOSKELETAL SYNDROME	0.002439494	0.09152042339826766
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.002439494	0.09152042339826766
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.002439494	0.09152042339826766
20Q11.2 MICRODELETION SYNDROME	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.002439494	0.09152042339826766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.002439494	0.09152042339826766
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.002439494	0.09152042339826766
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002439494	0.09152042339826766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.002439494	0.09152042339826766
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.002439494	0.09152042339826766
FETAL ALCOHOL SYNDROME	0.002439494	0.09152042339826766
FETAL TRIMETHADIONE SYNDROME	0.002439494	0.09152042339826766
FETAL HYDANTOIN SYNDROME	0.002439494	0.09152042339826766
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002439494	0.09152042339826766
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA	0.002439494	0.09152042339826766
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.002439494	0.09152042339826766
DISTAL TRISOMY 6P	0.002439494	0.09152042339826766
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.002439494	0.09152042339826766
SILVER-RUSSELL SYNDROME; SRS	0.002439494	0.09152042339826766
REVESZ SYNDROME	0.002439494	0.09152042339826766
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.002439494	0.09152042339826766
WARSAW BREAKAGE SYNDROME; WABS	0.002439494	0.09152042339826766
BRESEK SYNDROME	0.002439494	0.09152042339826766
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002439494	0.09152042339826766
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.002439494	0.09152042339826766
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.002439494	0.09152042339826766
SAUL-WILSON SYNDROME; SWILS	0.002439494	0.09152042339826766
TRISOMY 18	0.002439494	0.09152042339826766
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.002439494	0.09152042339826766
COLE-CARPENTER SYNDROME	0.002439494	0.09152042339826766
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002439494	0.09152042339826766
FLOATING-HARBOR SYNDROME	0.002439494	0.09152042339826766
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.002439494	0.09152042339826766
HOYERAAL-HREIDARSSON SYNDROME	0.002439494	0.09152042339826766
RABSON-MENDENHALL SYNDROME	0.002439494	0.09152042339826766
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.002439494	0.09152042339826766
MOSAIC TRISOMY 9	0.002439494	0.09152042339826766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002439494	0.09152042339826766
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002439494	0.09152042339826766
CUTIS LAXA	0.002439494	0.09152042339826766
GABRIELE-DE VRIES SYNDROME; GADEVS	0.002439494	0.09152042339826766
SYNDROMIC DIARRHEA	0.002439494	0.09152042339826766
DISTAL TRISOMY 15Q	0.002435359	0.09136529411705122
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.002435359	0.09136529411705122
4Q21 MICRODELETION SYNDROME	0.002435359	0.09136529411705122
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.002435359	0.09136529411705122
THANATOPHORIC DYSPLASIA	0.002435359	0.09136529411705122
DISTAL MONOSOMY 3P	0.002435359	0.09136529411705122
BRANCHIOOCULOFACIAL SYNDROME	0.002435359	0.09136529411705122
KAPUR-TORIELLO SYNDROME	0.002435359	0.09136529411705122
WIEDEMANN-STEINER SYNDROME	0.002435359	0.09136529411705122
HARROD SYNDROME	0.002435359	0.09136529411705122
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002435359	0.09136529411705122
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.002435359	0.09136529411705122
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.002435359	0.09136529411705122
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.002435359	0.09136529411705122
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002435359	0.09136529411705122
MARDEN-WALKER SYNDROME	0.002435359	0.09136529411705122
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002435359	0.09136529411705122
3-HYDROXYISOBUTYRIC ACIDURIA	0.002435359	0.09136529411705122
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.002435359	0.09136529411705122
DUBOWITZ SYNDROME	0.002435359	0.09136529411705122
RING CHROMOSOME 10 SYNDROME	0.002435359	0.09136529411705122
ACROCARDIOFACIAL SYNDROME	0.002435359	0.09136529411705122
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002435359	0.09136529411705122
BANGSTAD SYNDROME	0.002435359	0.09136529411705122
SECKEL SYNDROME 1; SCKL1	0.002435359	0.09136529411705122
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.002435359	0.09136529411705122
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002435359	0.09136529411705122
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.002435359	0.09136529411705122
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.002435359	0.09136529411705122
MENKES DISEASE	0.002435359	0.09136529411705122
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002435359	0.09136529411705122
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002435359	0.09136529411705122
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.002435359	0.09136529411705122
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.002435359	0.09136529411705122
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.002435359	0.09136529411705122
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002435359	0.09136529411705122
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.002435359	0.09136529411705122
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002435359	0.09136529411705122
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002435359	0.09136529411705122
RETINITIS PIGMENTOSA 59; RP59	0.002435359	0.09136529411705122
SECKEL SYNDROME 7; SCKL7	0.002435359	0.09136529411705122
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002435359	0.09136529411705122
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.002435359	0.09136529411705122
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002435359	0.09136529411705122
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00189394	0.07105333757365874
CAT-EYE SYNDROME	0.00189394	0.07105333757365874
NIJMEGEN BREAKAGE SYNDROME	0.00189394	0.07105333757365874
MONOSOMY 13Q14	0.00189394	0.07105333757365874
JUBERG-HAYWARD SYNDROME	0.00189394	0.07105333757365874
DISTAL MONOSOMY 10P	0.00189394	0.07105333757365874
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00189394	0.07105333757365874
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00189394	0.07105333757365874
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00189394	0.07105333757365874
MARTINEZ-FRIAS SYNDROME	0.00189394	0.07105333757365874
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00189394	0.07105333757365874
BARTSOCAS-PAPAS SYNDROME; BPS	0.00189394	0.07105333757365874
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00189394	0.07105333757365874
ENG-STROM SYNDROME	0.00189394	0.07105333757365874
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00189394	0.07105333757365874
ALAGILLE SYNDROME	0.00189394	0.07105333757365874
MONOSOMY 5P	0.00189394	0.07105333757365874
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.00189394	0.07105333757365874
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00189394	0.07105333757365874
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00189394	0.07105333757365874
LAMBOTTE SYNDROME	0.00189394	0.07105333757365874
HYDROLETHALUS SYNDROME 1	0.00189394	0.07105333757365874
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00189394	0.07105333757365874
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00189394	0.07105333757365874
NEU-LAXOVA SYNDROME 2; NLS2	0.00189394	0.07105333757365874
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00189394	0.07105333757365874
MEIER-GORLIN SYNDROME 8; MGORS8	0.00189394	0.07105333757365874
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.00189394	0.07105333757365874
CRANE-HEISE SYNDROME	0.00189394	0.07105333757365874
MULIBREY NANISM	0.00189394	0.07105333757365874
PROGEROID SYNDROME, PETTY TYPE	0.00189394	0.07105333757365874
TETRAPLOIDY	0.00189394	0.07105333757365874
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00189394	0.07105333757365874
ROIFMAN SYNDROME	0.00189394	0.07105333757365874
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00189394	0.07105333757365874
TETRALOGY OF FALLOT	0.00189394	0.07105333757365874
MODY	0.00189394	0.07105333757365874
JOHANSON-BLIZZARD SYNDROME	0.00189394	0.07105333757365874
RUSSELL-SILVER SYNDROME, X-LINKED	0.00189394	0.07105333757365874
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00189394	0.07105333757365874
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00189394	0.07105333757365874
SHORT SYNDROME	0.00189394	0.07105333757365874
FETAL AKINESIA DEFORMATION SEQUENCE	0.00189394	0.07105333757365874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00189394	0.07105333757365874
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00189394	0.07105333757365874
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00189394	0.07105333757365874
IMMUNODEFICIENCY 55; IMD55	0.00189394	0.07105333757365874
MOSAIC MONOSOMY X	0.00189394	0.07105333757365874
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00189394	0.07105333757365874
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00189394	0.07105333757365874
SECKEL SYNDROME	0.00189394	0.07105333757365874
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00189394	0.07105333757365874
THAKKER-DONNAI SYNDROME	0.00189394	0.07105333757365874
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00189394	0.07105333757365874
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00189394	0.07105333757365874
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00189394	0.07105333757365874
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00189394	0.07105333757365874
ACRORENAL-MANDIBULAR SYNDROME	0.00189394	0.07105333757365874
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00189394	0.07105333757365874
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.07105333757365874
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00189394	0.07105333757365874
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00189394	0.07105333757365874
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00189394	0.07105333757365874
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00189394	0.07105333757365874
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00189394	0.07105333757365874
MEIER-GORLIN SYNDROME 1; MGORS1	0.00189394	0.07105333757365874
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00189394	0.07105333757365874
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00189394	0.07105333757365874
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00189394	0.07105333757365874
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00189394	0.07105333757365874
MECKEL SYNDROME, TYPE 1; MKS1	0.00189394	0.07105333757365874
MONOSOMY X	0.00189394	0.07105333757365874
MEIER-GORLIN SYNDROME 5; MGORS5	0.00189394	0.07105333757365874
RESTRICTIVE DERMOPATHY	0.00189394	0.07105333757365874
MECKEL SYNDROME, TYPE 4; MKS4	0.00189394	0.07105333757365874
VERVERI-BRADY SYNDROME; VERBRAS	0.00189394	0.07105333757365874
MEIER-GORLIN SYNDROME 3; MGORS3	0.00189394	0.07105333757365874
BRADDOCK SYNDROME	0.00189394	0.07105333757365874
METHIMAZOLE EMBRYOFETOPATHY	0.00189394	0.07105333757365874
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00189394	0.07105333757365874
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00189394	0.07105333757365874
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00189394	0.07105333757365874
DIASTROPHIC DWARFISM	0.00189394	0.07105333757365874
STIMMLER SYNDROME	0.00189394	0.07105333757365874
TRICHOHEPATOENTERIC SYNDROME 1	0.00189394	0.07105333757365874
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00189394	0.07105333757365874
MEIER-GORLIN SYNDROME 2; MGORS2	0.00189394	0.07105333757365874
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00189394	0.07105333757365874
APPARENT MINERALOCORTICOID EXCESS	0.00189394	0.07105333757365874
SECKEL SYNDROME 4	0.00189394	0.07105333757365874
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.07105333757365874
ISOTRETINOIN-LIKE SYNDROME	0.00189394	0.07105333757365874
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.07105333757365874
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00189394	0.07105333757365874
ELLIS VAN CREVELD SYNDROME	0.00189394	0.07105333757365874
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00189394	0.07105333757365874
VACTERL WITH HYDROCEPHALUS	0.00189394	0.07105333757365874
MECKEL SYNDROME 12; MKS12	0.00189394	0.07105333757365874
BLOOM SYNDROME	0.00189394	0.07105333757365874
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00189394	0.07105333757365874
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00189394	0.07105333757365874
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00189394	0.07105333757365874
LAMBERT SYNDROME	0.00189394	0.07105333757365874
BRANCHIO-OCULO-FACIAL SYNDROME	0.00189394	0.07105333757365874
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00189394	0.07105333757365874
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00189394	0.07105333757365874
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00189394	0.07105333757365874
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.07105333757365874
NEUROFACIODIGITORENAL SYNDROME	0.00189394	0.07105333757365874
NEU-LAXOVA SYNDROME	0.00189394	0.07105333757365874
MITCHELL-RILEY SYNDROME; MTCHRS	0.00189394	0.07105333757365874
BLOOM SYNDROME	0.00189394	0.07105333757365874
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00189394	0.07105333757365874
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00189394	0.07105333757365874
BALLER-GEROLD SYNDROME	0.00189394	0.07105333757365874
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00189394	0.07105333757365874
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00189394	0.07105333757365874
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00189394	0.07105333757365874
HOLZGREVE SYNDROME	0.00189394	0.07105333757365874
19Q13.11 MICRODELETION SYNDROME	0.00189394	0.07105333757365874
HEMOCHROMATOSIS, NEONATAL	0.00189394	0.07105333757365874
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00189394	0.07105333757365874
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.07105333757365874
ACRO-RENAL-MANDIBULAR SYNDROME	0.00189394	0.07105333757365874
FRAXE INTELLECTUAL DISABILITY	0.00189394	0.07105333757365874
AREDYLD SYNDROME	0.00189394	0.07105333757365874
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.07105333757365874
HARTSFIELD SYNDROME	0.00189394	0.07105333757365874
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00189394	0.07105333757365874
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00189394	0.07105333757365874
LEPRECHAUNISM	0.00189394	0.07105333757365874
TRIPLOIDY	0.00189394	0.07105333757365874
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00189394	0.07105333757365874
TRANSALDOLASE DEFICIENCY	0.00189394	0.07105333757365874
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00189394	0.07105333757365874
ATRESIA OF SMALL INTESTINE	0.00189394	0.07105333757365874
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.07105333757365874
MATTHEW-WOOD SYNDROME	0.00189394	0.07105333757365874
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00189394	0.07105333757365874
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00189394	0.07105333757365874
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.07105333757365874
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00189394	0.07105333757365874
GRACILE SYNDROME	0.00189394	0.07105333757365874
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00189394	0.07105333757365874
PEARSON SYNDROME	0.00189394	0.07105333757365874
CEREBROCOSTOMANDIBULAR SYNDROME	0.00189394	0.07105333757365874
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00189394	0.07105333757365874
3M SYNDROME	0.00189394	0.07105333757365874
PHAVER SYNDROME	0.00189394	0.07105333757365874
GENITOPALATOCARDIAC SYNDROME	0.00189394	0.07105333757365874
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00189394	0.07105333757365874
IMAGE SYNDROME	0.00189394	0.07105333757365874
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.07105333757365874
PHOCOMELIA, SCHINZEL TYPE	0.00189394	0.07105333757365874
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00189394	0.07105333757365874
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00189394	0.07105333757365874
TURNER SYNDROME	0.00189394	0.07105333757365874
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00189394	0.07105333757365874
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00189394	0.07105333757365874
JOHANSON-BLIZZARD SYNDROME; JBS	0.00189394	0.07105333757365874
TRICHOHEPATOENTERIC SYNDROME 2	0.00189394	0.07105333757365874
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00189394	0.07105333757365874
MEVALONIC ACIDURIA	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
SSR4-CDG	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
ELEJALDE DISEASE	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
49,XXXXY SYNDROME	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040779042368001395
SMITH-MAGENIS SYNDROME; SMS	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
STT3A-CDG	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040779042368001395
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
GRISCELLI SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.040779042368001395
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.040779042368001395
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040779042368001395
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.040779042368001395
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040779042368001395
KLEEFSTRA SYNDROME	0.001086973	0.040779042368001395
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.040779042368001395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040779042368001395
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.040779042368001395
SALLA DISEASE	0.001086973	0.040779042368001395
FUCOSIDOSIS	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
17Q12 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.040779042368001395
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
WALKER-WARBURG SYNDROME	0.001086973	0.040779042368001395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
DISTAL TRISOMY 17Q	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
15Q14 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
MONOSOMY 9P	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
8P11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001086973	0.040779042368001395
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
DISTAL MONOSOMY 1Q	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040779042368001395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
CK SYNDROME	0.001086973	0.040779042368001395
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
GRISCELLI SYNDROME TYPE 1	0.001086973	0.040779042368001395
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.001086973	0.040779042368001395
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001086973	0.040779042368001395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.040779042368001395
SIALIDOSIS TYPE 2	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040779042368001395
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.040779042368001395
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
C SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040779042368001395
19P13.13 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
MEND SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.040779042368001395
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.040779042368001395
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001086973	0.040779042368001395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
RING CHROMOSOME 22 SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
PIERPONT SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.040779042368001395
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001086973	0.040779042368001395
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
LISSENCEPHALY 1; LIS1	0.001086973	0.040779042368001395
COACH SYNDROME	0.001086973	0.040779042368001395
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
RUBINSTEIN-TAYBI SYNDROME	0.001086973	0.040779042368001395
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.040779042368001395
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
2Q37 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.040779042368001395
POTOCKI-SHAFFER SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.040779042368001395
AICARDI-GOUTIÈRES SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001086973	0.040779042368001395
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.040779042368001395
MONOSOMY 9Q22.3	0.001086973	0.040779042368001395
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040779042368001395
WEAVER SYNDROME	0.001086973	0.040779042368001395
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.040779042368001395
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040779042368001395
ANGELMAN SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040779042368001395
MEHMO SYNDROME; MEHMO	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
CHROMOSOME 10Q26 DELETION SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.040779042368001395
SMITH-MAGENIS SYNDROME	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001086973	0.040779042368001395
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.040779042368001395
48,XXXY SYNDROME	0.001086973	0.040779042368001395
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
KABUKI SYNDROME 1	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
EAST SYNDROME	0.001086973	0.040779042368001395
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
LISSENCEPHALY 8; LIS8	0.001086973	0.040779042368001395
HARTNUP DISEASE	0.001086973	0.040779042368001395
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.040779042368001395
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040779042368001395
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.040779042368001395
COWDEN SYNDROME	0.001086973	0.040779042368001395
GLASS SYNDROME	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
11Q22.2Q22.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.040779042368001395
22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
PMM2-CDG	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001086973	0.040779042368001395
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.040779042368001395
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.020467085824608922
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608922
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.020467085824608922
CURRY-JONES SYNDROME	0.000545554	0.020467085824608922
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020467085824608922
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608922
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 14	0.000545554	0.020467085824608922
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608922
JOUBERT SYNDROME 15	0.000545554	0.020467085824608922
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020467085824608922
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020467085824608922
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020467085824608922
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608922
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020467085824608922
CDAGS SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020467085824608922
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
48,XYYY SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.020467085824608922
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
LIG4 SYNDROME	0.000545554	0.020467085824608922
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.020467085824608922
NOONAN SYNDROME 5; NS5	0.000545554	0.020467085824608922
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020467085824608922
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608922
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608922
JOUBERT SYNDROME 8	0.000545554	0.020467085824608922
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020467085824608922
HADZISELIMOVIC SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.020467085824608922
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.020467085824608922
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020467085824608922
RIDDLE SYNDROME	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.020467085824608922
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020467085824608922
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020467085824608922
NOONAN SYNDROME 3; NS3	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020467085824608922
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020467085824608922
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020467085824608922
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020467085824608922
LARSEN-LIKE SYNDROME	0.000545554	0.020467085824608922
3Q29 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020467085824608922
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608922
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020467085824608922
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020467085824608922
LIG4 SYNDROME	0.000545554	0.020467085824608922
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020467085824608922
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
TRANSKETOLASE DEFICIENCY	0.000545554	0.020467085824608922
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020467085824608922
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020467085824608922
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
FRIED SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020467085824608922
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020467085824608922
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608922
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608922
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020467085824608922
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608922
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020467085824608922
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020467085824608922
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608922
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020467085824608922
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608922
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608922
WEAVER SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 11	0.000545554	0.020467085824608922
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020467085824608922
YUNIS-VARON SYNDROME	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
PROPIONIC ACIDEMIA	0.000545554	0.020467085824608922
RIGID SPINE SYNDROME	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020467085824608922
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608922
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020467085824608922
NOONAN SYNDROME 6; NS6	0.000545554	0.020467085824608922
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020467085824608922
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020467085824608922
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020467085824608922
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020467085824608922
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
FRONTOOCULAR SYNDROME	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020467085824608922
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608922
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020467085824608922
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020467085824608922
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020467085824608922
RAINE SYNDROME	0.000545554	0.020467085824608922
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608922
GERMAN SYNDROME	0.000545554	0.020467085824608922
OROTIC ACIDURIA	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608922
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020467085824608922
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.020467085824608922
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.020467085824608922
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020467085824608922
MECKEL SYNDROME 13; MKS13	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.020467085824608922
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020467085824608922
3MC SYNDROME 2	0.000545554	0.020467085824608922
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020467085824608922
TOLUENE EMBRYOPATHY	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.020467085824608922
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020467085824608922
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
PELLAGRA-LIKE SYNDROME	0.000545554	0.020467085824608922
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.020467085824608922
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608922
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.020467085824608922
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020467085824608922
ICF SYNDROME	0.000545554	0.020467085824608922
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
3C SYNDROME	0.000545554	0.020467085824608922
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020467085824608922
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
TRISOMY 9P	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.020467085824608922
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020467085824608922
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
ZECHI-CEIDE SYNDROME	0.000545554	0.020467085824608922
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
NAVAJO NEUROHEPATOPATHY	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.020467085824608922
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 28	0.000545554	0.020467085824608922
JOUBERT SYNDROME 27	0.000545554	0.020467085824608922
MEIER-GORLIN SYNDROME 7	0.000545554	0.020467085824608922
HYPERTRICHOSIS CUBITI	0.000545554	0.020467085824608922
NETHERTON SYNDROME; NETH	0.000545554	0.020467085824608922
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.020467085824608922
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.020467085824608922
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020467085824608922
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608922
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020467085824608922
CODAS SYNDROME	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608922
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
OGDEN SYNDROME; OGDNS	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020467085824608922
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
PENTASOMY X	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608922
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020467085824608922
NOONAN SYNDROME 11; NS11	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020467085824608922
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608922
300270 ADRENOMYODYSTROPHY	0.000545554	0.020467085824608922
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.020467085824608922
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 10	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020467085824608922
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
TRISOMY 12P	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
DISTAL TRISOMY 18Q	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.020467085824608922
6Q16 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.020467085824608922
TRISOMY 8Q	0.000545554	0.020467085824608922
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020467085824608922
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.020467085824608922
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
HOLMES-GANG SYNDROME	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
DEXTROCARDIA	0.000545554	0.020467085824608922
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020467085824608922
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608922
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608922
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
MONOSOMY 18P	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020467085824608922
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020467085824608922
DISTAL MONOSOMY 9P	0.000545554	0.020467085824608922
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608922
EVEN-PLUS SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020467085824608922
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020467085824608922
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608922
OGDEN SYNDROME	0.000545554	0.020467085824608922
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.020467085824608922
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.020467085824608922
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020467085824608922
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020467085824608922
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
THYROID HEMIAGENESIS	0.000545554	0.020467085824608922
OPITZ G/BBB SYNDROME	0.000545554	0.020467085824608922
THYROID HYPOPLASIA	0.000545554	0.020467085824608922
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020467085824608922
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608922
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608922
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608922
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.020467085824608922
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020467085824608922
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608922
OXOGLUTARIC ACIDURIA	0.000545554	0.020467085824608922
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
SAY-BARBER-MILLER SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.020467085824608922
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.020467085824608922
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020467085824608922
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.020467085824608922
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608922
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020467085824608922
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.020467085824608922
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608922
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020467085824608922
MONOSOMY 13Q34	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020467085824608922
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
AL-RAQAD SYNDROME; ARS	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020467085824608922
THYROID ECTOPIA	0.000545554	0.020467085824608922
TETRASOMY X	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608922
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.020467085824608922
AU-KLINE SYNDROME; AUKS	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.020467085824608922
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020467085824608922
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608922
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608922
MIETENS SYNDROME	0.000545554	0.020467085824608922
LAMB-SHAFFER SYNDROME	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020467085824608922
JOUBERT SYNDROME 26	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020467085824608922
2Q32Q33 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020467085824608922
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020467085824608922
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608922
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020467085824608922
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608922
ATHYREOSIS	0.000545554	0.020467085824608922
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608922
CHOPS SYNDROME; CHOPS	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020467085824608922
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020467085824608922
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.020467085824608922
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608922
JOUBERT SYNDROME 25	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020467085824608922
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
ANGELMAN SYNDROME	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
COG8-CDG	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
RETT SYNDROME	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
XERODERMA PIGMENTOSUM	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
CAMOS SYNDROME	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
PROTEUS SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
ADDISON DISEASE	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
LASSA FEVER	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392476
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.020311956543392476
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
CYCLIC VOMITING SYNDROME	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392476
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392476
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392476
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020311956543392476
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392476
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020311956543392476
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.020311956543392476
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020311956543392476
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020311956543392476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392476
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
PHENYLKETONURIA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
GITELMAN SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392476
GAPO SYNDROME; GAPOS	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
OHDO SYNDROME	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
LEIGH SYNDROME	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
14Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392476
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
DDOST-CDG	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392476
HENNEKAM SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
MOWAT-WILSON SYNDROME	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392476
KABUKI SYNDROME	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
TEMPLE-BARAITSER SYNDROME	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392476
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
CHIME SYNDROME	0.000541419	0.020311956543392476
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
DUPLICATION/INVERSION 15Q11	0.000541419	0.020311956543392476
TETRASOMY 18P	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
WHIPPLE DISEASE	0.000541419	0.020311956543392476
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392476
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392476
ATAXIA-TELANGIECTASIA	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392476
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
COCKAYNE SYNDROME	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
C SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392476
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392476
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
